<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Non‐pharmacological interventions for chronic pain in multiple sclerosis - Amatya, B - 2018 | Cochrane Library</title> <meta content="Non‐pharmacological interventions for chronic pain in multiple sclerosis - Amatya, B - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012622.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Non‐pharmacological interventions for chronic pain in multiple sclerosis - Amatya, B - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012622.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012622.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Non‐pharmacological interventions for chronic pain in multiple sclerosis" name="citation_title"/> <meta content="Bhasker Amatya" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="Bhasker.Amatya@mh.org.au" name="citation_author_email"/> <meta content="Jamie Young" name="citation_author"/> <meta content="Melbourne Health" name="citation_author_institution"/> <meta content="Fary Khan" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD012622.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/12/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012622.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012622.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012622.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chronic Pain [*therapy]; Exercise Therapy [methods]; Hydrotherapy; Hypnosis; Massage; Multiple Sclerosis [*complications]; Musculoskeletal Pain [*therapy]; Neurofeedback; Patient Education as Topic [methods]; Psychotherapy; Quality of Life; Randomized Controlled Trials as Topic; Relaxation Therapy; Transcranial Direct Current Stimulation; Transcutaneous Electric Nerve Stimulation [methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012622.pub2&amp;doi=10.1002/14651858.CD012622.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012622\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012622\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012622.pub2",title:"Non\\u2010pharmacological interventions for chronic pain in multiple sclerosis",firstPublishedDate:"Dec 19, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012622.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012622.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012622.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012622.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012622.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012622.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012622.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012622.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012622.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012622.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14557 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012622.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-sec-0078"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/appendices#CD012622-sec-0088"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Non‐pharmacological interventions for chronic pain in multiple sclerosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#CD012622-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Bhasker Amatya</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#CD012622-cr-0003">Jamie Young</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information#CD012622-cr-0004">Fary Khan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information/en#CD012622-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 December 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012622.pub2">https://doi.org/10.1002/14651858.CD012622.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012622-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012622-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012622-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012622-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012622-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012622-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012622-abs-0001" lang="en"> <section id="CD012622-sec-0001"> <h3 class="title" id="CD012622-sec-0001">Background</h3> <p>Chronic pain is common and significantly impacts on the lives of persons with multiple sclerosis (pwMS). Various types of non‐pharmacological interventions are widely used, both in hospital and ambulatory/mobility settings to improve pain control in pwMS, but the effectiveness and safety of many non‐pharmacological modalities is still unknown. </p> </section> <section id="CD012622-sec-0002"> <h3 class="title" id="CD012622-sec-0002">Objectives</h3> <p>This review aimed to investigate the effectiveness and safety of non‐pharmacological therapies for the management of chronic pain in pwMS. Specific questions to be addressed by this review include the following. </p> <p>Are non‐pharmacological interventions (unidisciplinary and/or multidisciplinary rehabilitation) effective in reducing chronic pain in pwMS? </p> <p>What type of non‐pharmacological interventions (unidisciplinary and/or multidisciplinary rehabilitation) are effective (least and most effective) and in what setting, in reducing chronic pain in pwMS? </p> </section> <section id="CD012622-sec-0003"> <h3 class="title" id="CD012622-sec-0003">Search methods</h3> <p>A literature search was performed using the specialised register of the Cochrane MS and Rare Diseases of the Central Nervous System Review Group, using the Cochrane MS Group Trials Register which contains CENTRAL, MEDLINE, Embase, CINAHL, LILACUS, Clinical trials.gov and the World Health Organization International Clinical Trials Registry Platform on 10 December 2017. Handsearching of relevant journals and screening of reference lists of relevant studies was carried out. </p> </section> <section id="CD012622-sec-0004"> <h3 class="title" id="CD012622-sec-0004">Selection criteria</h3> <p>All published randomised controlled trials (RCTs)and cross‐over studies that compared non‐pharmacological therapies with a control intervention for managing chronic pain in pwMS were included. Clinical controlled trials (CCTs) were eligible for inclusion. </p> </section> <section id="CD012622-sec-0005"> <h3 class="title" id="CD012622-sec-0005">Data collection and analysis</h3> <p>All three review authors independently selected studies, extracted data and assessed the methodological quality of the studies using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) tool for best‐evidence synthesis. Pooling data for meta‐analysis was not possible due to methodological, clinical and statistically heterogeneity of the included studies. </p> </section> <section id="CD012622-sec-0006"> <h3 class="title" id="CD012622-sec-0006">Main results</h3> <p>Overall, 10 RCTs with 565 participants which investigated different non‐pharmacological interventions for the management of chronic pain in MS fulfilled the review inclusion criteria. The non‐pharmacological interventions evaluated included: transcutaneous electrical nerve stimulation (TENS), psychotherapy (telephone self‐management, hypnosis and electroencephalogram (EEG) biofeedback), transcranial random noise stimulation (tRNS), transcranial direct stimulation (tDCS), hydrotherapy (Ai Chi) and reflexology. </p> <p>There is <i>very low‐level evidence</i> for the use of non‐pharmacological interventions for chronic pain such as TENS, Ai Chi, tDCS, tRNS, telephone‐delivered self‐management program, EEG biofeedback and reflexology in pain intensity in pwMS. Although there were improved changes in pain scores and secondary outcomes (such as fatigue, psychological symptoms, spasm in some interventions), these were limited by methodological biases within the studies. </p> </section> <section id="CD012622-sec-0007"> <h3 class="title" id="CD012622-sec-0007">Authors' conclusions</h3> <p>Despite the use of a wide range of non‐pharmacological interventions for the treatment of chronic pain in pwMS, the evidence for these interventions is still limited or insufficient, or both. More studies with robust methodology and greater numbers of participants are needed to justify the effect of these interventions for the management of chronic pain in pwMS. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012622-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012622-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012622-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012622-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012622-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012622-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012622-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012622-abs-0006">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012622-abs-0005" lang="en"> <h3>[Non‐pharmacological interventions for chronic pain in multiple sclerosis]</h3> <p><b>Review Question</b> </p> <p>Do non‐medication treatments improve chronic pain in multiple sclerosis (MS) in comparison to inactive treatment? </p> <p><b>Background</b> </p> <p>Chronic pain in people with MS (pwMS) is common, and treatment with medications can be associated with and limited by side effects such as confusion, falls, dizziness and drowsiness. Many non‐medication treatments are used to treat chronic pain in pwMS, which include exercise, psychology, electrical stimulation therapy, reflexology and others. </p> <p><b>Search Date</b> </p> <p>We included all randomised clinical trials (clinical studies where people are randomly put into one of two or more intervention groups), which were published up to December 2017. </p> <p><b>Study Characteristics</b> </p> <p>Overall, we found 10 studies evaluating different non‐medication treatments to treat chronic pain in persons with MS. The treatments evaluated included: transcutaneous electrical nerve stimulation, transcranial direct stimulation, transcranial random noise stimulation, reflexology, psychotherapy and hydrotherapy. These studies included 565 participants and used a range of different methods to measure pain and other outcomes. Comparison groups also varied. </p> <p><b>Key Results</b> </p> <p>Results from these studies show a very low level of evidence for the use of any non‐medication treatments for chronic pain in persons with MS. </p> <p><b>Quality of Evidence</b> </p> <p>We assessed the overall quality of the studies as very low, as many studies included only small numbers of participants and had other methodological issues. More research with good methodological quality and greater number of participants are needed to determine the effectiveness of such treatments. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012622-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012622-sec-0084"></div> <h3 class="title" id="CD012622-sec-0085">Implications for practice</h3> <section id="CD012622-sec-0085"> <p>Despite use of a range of non‐pharmacological interventions for the treatment of chronic pain in persons with multiple sclerosis (pwMS), this review found '<i>very low‐level'</i> evidence for the use of such interventions. Therefore, it is difficult to recommend routine use of non‐pharmacological interventions alone for the treatment of chronic pain in an MS population. However, findings suggest that use of non‐pharmacological intervention in combination with pharmacological agents is reasonable. The findings of this review also highlight the existing gaps in the literature and emphasise the need for robust evidence to support these modalities. Clinician involvement is vital to build evidence from everyday clinical practice. The clinical applicability of findings of this review need to be confirmed in future studies with robust study design, larger sample sizes and long‐term follow‐up. </p> </section> <h3 class="title" id="CD012622-sec-0086">Implications for research</h3> <section id="CD012622-sec-0086"> <p>This review shows that there are significant gaps in the literature on non‐pharmacological management of chronic pain in MS. Future research implications include the following. </p> <p> <ul id="CD012622-list-0017"> <li> <p>Robust studies with reduced risk of bias, with adequate allocation, randomisation procedures </p> </li> <li> <p>Standard reporting of pain as defined by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (<a href="./references#CD012622-bbs2-0049" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Pain2008;9(2):105‐21. ">Dworkin 2008</a>) </p> </li> <li> <p>Reporting pain measures desired by patients (<a href="./references#CD012622-bbs2-0091" title="MooreR , StraubeS , AldingtonD . Pain measures and cut‐offs ‐ 'no worse than mild pain' as a simple, universal outcome. Anaesthesia2013;68(4):400‐12. ">Moore 2013</a>) </p> </li> <li> <p>Appropriate and careful selection of study cohort and larger sample size</p> </li> <li> <p>Emphasise on details of pain mechanism, localisation pattern, severity and impact on everyday function </p> </li> <li> <p>Impact and burden on carer and family, or both</p> </li> <li> <p>Intervention‐related adverse effects/complications</p> </li> <li> <p>Long‐term impact of interventions</p> </li> <li> <p>Cost associated with the interventions</p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012622-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012622-sec-0029"></div> <div class="table" id="CD012622-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transcutaneous Electrical Nerve Stimulation (TENS) compared to Sham for Chronic Back Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcutaneous electrical nerve stimulation (TENS) compared to sham for chronic back pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic back pain in MS<br/> <b>Setting:</b> participants from Multiple Sclerosis Society in Northern Ireland<br/> <b>Intervention:</b> TENS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i> </p> <p>assessed with: VAS, MPQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Decrease in low back pain scores overtime for all groups, however, none reached clinical or statistical significance in VAS scores. No statistically significant changes in MPQ (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). VAS mean reduction for TENS low frequency at week 6 was ‐16.59 (weekly low back pain) and ‐19.76 (average low back pain). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i> </p> <p>assessed with: RMDQ, BI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant changes in disability measured by RMDQ and BI between treatment and placebo groups and within‐groups (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Quality of Life</b> </i> </p> <p>assessed with: LMSQoLQ, SF‐36</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant difference in quality of life measured by LMSQoLQ or SF‐36 between treatment and placebo groups (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BI:</b> Barthel Index; <b>MPQ:</b> McGill Pain Questionnaire; <b>LMSQoLQ</b> : Leeds Multiple Sclerosis Quality of Life Questionnaire; <b>RMDQ:</b> Roland Morris Disability Questionnaire; <b>SF‐36</b> : Short Form 36; <b>VAS:</b> Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels due to high risk for bias (unclear allocation concealment) </p> <p><sup>2</sup>Downgraded two levels due to high risk of bias for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ai Chi Exercises compared to Sham for Chronic Musculoskeletal pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Ai Chi exercises compared to sham for chronic musculoskeletal pain in multiple sclerosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic musculoskeletal pain in people with MS<br/> <b>Setting:</b> participants were recruited from MS Association of Almeria in Spain<br/> <b>Intervention:</b> Ai Chi exercises<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i> </p> <p>assessed with: VAS, MPQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant reduction in pain scores measured by VAS in the treatment group immediately after treatment and no significant change from baseline in the control group. Pain VAS at week 20 was 50% (experimental) and 23% (control). </p> <p>Significant pain reduction for MPQ in the treatment group and no significant change from baseline in the control group (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i> </p> <p>assessed with: RMDQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant reduction in disability measured by RMDQ in intervention and control group at week 20 (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Quality of Life</b> </i> </p> <p>assessed with: MSIS‐29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both groups showed a significant reduction in the psychological sub scale of the MFIS at week 20. Treatment group showed significant score reduction but the control group showed no significant difference with baseline score in the physical sub scale at week 20 (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Fatigue</b> </i><br/> assessed with:MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Treatment group showed a significant score reduction compared with baseline at week 20, but no significant difference in control group. Treatment group showed a significant reduction in cognitive scale compared with the control group (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>MFIS:</b> Modified Fatigue Impact Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>MSIS‐29</b> : Multiple Sclerosis Impact Scale‐29; <b>RMDQ:</b> Roland Morris Disability Questionnaire, <b>SF‐36</b> : Short Form 36; <b>VAS</b>: Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels because the singular study was considered at serious risk of performance bias ( blinding of participants and personnel ) and unclear risk of allocation concealment </p> <p><sup>2</sup> Downgraded two levels due to imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Transcranial Direct Current Stimulation (tDCS) compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcranial direct current stimulation (tDCS) compared to sham for chronic neuropathic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic neuropathic pain in MS<br/> <b>Setting</b> : community neurology clinic<br/> <b>Intervention:</b> tDCS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Pain Intensity</b> </i><br/> assessed with: VAS, BPI, MPQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain VAS showed significant decrease after active tDCS (mean baseline 51.2; after treatment 43.1) but no significant change after sham (mean baseline 52.1; after treatment 50.3). BPI global score for active tDCS resulted in significant improvement on the interference sub scale but no significant effects on the severity sub scale (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> <p>Significant main effect of time for decreased daily pain VAS (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LO</b>W <sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>There was no significant difference in fatigue measured by the MFIS between groups (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in depression and anxiety</b> </i><br/> assessed with: BDI, HADS, VAS for anxiety </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant differences in depression and anxiety were observed for both groups on HADS (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> <p>No significant changes for BDI and VAS for anxiety with time as within subjects and group of treatment as between subjects. (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in QoL</b> </i><br/> assessed with: MSQOL54 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant effect of time and group x time interaction for improved quality of life measured by the MSQOL54 (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BDI:</b> Beck Depression Inventory; <b>HADS</b> : Hospital Anxiety and Depression Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>MSQOL54:</b> Multiple Sclerosis Quality of Life 54. <b>QoL</b> : Quality of life, <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for risk for bias (the two studies at unclear risk of bias in allocation concealment) </p> <p><sup>2</sup> Downgraded two levels for high risk for imprecision (small sample sizes of both studies) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Transcranial Random Noise Stimulation (tRNS)compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcranial Random Noise Stimulation (tRNS) compared to sham for chronic neuropathic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic neuropathic pain in MS<br/> <b>Setting:</b> hospital MS clinics<br/> <b>Intervention:</b> tRNS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain</b> </i><br/> assessed with: VAS, BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistically significant changes for mean pain VAS treatment (mean VAS before 50.1; mean<br/> VAS after 47.2) and sham groups (mean VAS before: 52.1; mean VAS after:50.3). </p> <p>No statistical significance before and after stimulation sham and treatment for BPI (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in anxiety and depression</b> </i><br/> assessed with: HADS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistical significance before and after for treatment and sham for mean HADS (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistical significance before and after sham and treatment for mean total score (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Beck Pain Inventory; <b>HADS</b> : Hospital Anxiety and Depression Scale; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels because the singular study was considered at high risk of bias (unclear risk of bias in randomisation sequence generation, allocation concealment and blinding of outcome assessors) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Telephone‐Delivered Education Group compared to Sham for Chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Telephone‐delivered education compared to sham for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> participants' home across United States<br/> <b>Intervention:</b> telephone‐delivered education group<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference, depression,fatigu</b> </i>e<br/> assessed with: BPI, PHQ‐9, MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58% of telephone self‐management group and 46% of telephone education group had &gt; 50% reduction in 1 or more symptoms (fatigue, pain, depression), but not statistically significant (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>163<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in pain, self efficacy,patient activation, health‐related quality of life, social role satisfaction,resilience,positive and negative affect</b> </i><br/> assessed with: Average Pain Intensity, UWSES, Patient Activation Measure, Medical Outcomes Study 8 Item Short Form Heath Survey, Patient Reported Outcomes Measurement Information System Short‐Form,Connor‐Davidson Resilience Scale </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant improvements in all secondary outcomes for fatigue, pain interference, self efficacy and QoLcompared with telephone education group (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>163<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>PHQ‐9</b> :Patient Health Questionnaire 9; <b>QoL</b> : quality of life; <b>UWSES</b>:University of Washington Self Efficacy Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk of bias (the singular study at high risk of bias in blinding of outcome assessor and attrition) </p> <p><sup>2</sup> Downgraded two levels due to high risk of bias for imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Hypnosis compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Hypnosis compared to relaxation/control for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics<br/> <b>Intervention:</b> hypnosis<br/> <b>Comparison:</b> relaxation/control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i><br/> assessed with: Average Pain Intensity, Daily Pain Intensity (Numeric Rating Scale) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant changes pre and post treatment for hypnosis group but not in progressive relaxation group. Statistically significant decrease in daily/average pain scores for the self hypnosis group but not significant in the progressive muscle relaxation group (<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference</b> </i><br/> assessed with: BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant change pre to post treatment in the hypnosis group but not in the progressive relaxation group (<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk for bias (the singular study did not describe whether blinding had occurred for participants) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Neurofeedback compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Neurofeedback compared to relaxation/control for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics<br/> <b>Intervention:</b> neurofeedback<br/> <b>Comparison:</b> relaxation/control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain Intensity</b> </i><br/> assessed with: Numerical Rating Scale (average) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both groups improved soon after intervention and at 1‐month follow‐up, but not statically significant. Average mean pain intensity for intervention (before 5.30; after:4.41; 1 month 3.98) and control (before 5.24; after 4.32; 1 month 4.31). Worst pain intensity score improvements in intervention (before 6.68; after 5.90; 1 month 5.18) and control (before 6.38; after 5.49; 1 month 5.35) (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: FSS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Improvements over time pre to post treatment in intervention (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference</b> </i><br/> assessed with: BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>BPI score improvement in both groups (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory;<b>FSS:</b> Fatigue Severity Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk for bias (unclear allocation concealment and no blinding of outcome assessors) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012622-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Reflexology compared to Sham for Chronic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Reflexology compared to sham for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics, MS society<br/> <b>Intervention:</b> reflexology<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain</b> </i><br/> assessed with: VAS, MPQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Compared to baseline; significant decrease in median pain VAS in both reflexology (50% decrease at week 10) and sham (50% decrease at week 10) (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). Significant reduction in BPI scores in both groups, reflex group but no significant differences between groups. (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> <p>There were changes in mean pain VAS in both reflexology (pre‐test 5.72, post‐test 3.16, 2 months 4.64) and control (pre‐test 5.88, post‐test 5.60, 2 months 5.32) (<a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i><br/> assessed with: BI, RMDQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both the intervention and sham groups showed a significant decrease in RMDQ by the end of the treatment period.BI scores in both groups remained relatively stable throughout the duration of the trial in both groups (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in Quality of Life</b> </i><br/> assessed with: MSIS‐29 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MSIS‐29 psychological sub scale improved in both intervention and sham by week 10.</p> <p>Physical sub scale significant decrease in both intervention and sham, however this reduction was greater in the treatment group by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Fatigue</b> </i> <br/> assessed with: MFIS, FSS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MFIS physical sub scale score significantly improved in both sham and treatment by week 10. </p> <p>Significant reduction MFIS cognitive sub scale score in both sham and treatment by week 10. </p> <p>Significant reduction in MFIS psychological sub scale in both sham and treatment by the end of the treatment period. </p> <p>Both sham and treatment demonstrated a significant reduction in fatigue by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in depression</b> </i><br/> assessed with: BDI ‐II </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both sham and treatment groups showed a significant reduction in values by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Spasms</b> </i><br/> assessed with: VAS for spasm </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both sham and treatment demonstrated a statistically significant decrease in spasm by the end of the treatment (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>).. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BDI:</b> Beck Depression Inventory; <b>BI</b> : Barthel Index; FSS: Fatigue Severity ScLE; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>MSIS‐29</b> : Multiple Sclerosis Impact Scale‐29; <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk of attrition bias and unclear risk of bias in blinding and allocation concealment </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012622-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012622-sec-0030"></div> <p>All technical terms used are listed in a Glossary (<a href="./appendices#CD012622-sec-0089">Appendix 1</a>). </p> <p>Multiple sclerosis (MS) is a chronic neurological disease characterised by unpredictable patchy inflammation, scarring and demyelination of the central nervous system (CNS). Despite advances in MS management, it remains one of the most common causes of neurological disability in young adults, affecting 1.3 million people worldwide (<a href="./references#CD012622-bbs2-0120" title="World Health Organization (WHO). Atlas: Multiple sclerosis resources in the world. www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf (accessed 10 October 2016). ">WHO 2008</a>) and approximately 20,000 persons in Australia (<a href="./references#CD012622-bbs2-0093" title="MS Society Australia. MS Australia. www.msaustralia.org.au/ (accessed 10 October 2016). ">MS Society 2011</a>). The median estimated incidence of MS globally is 2.5 per 100,000 (range of 1.1 to 4) (<a href="./references#CD012622-bbs2-0120" title="World Health Organization (WHO). Atlas: Multiple sclerosis resources in the world. www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf (accessed 10 October 2016). ">WHO 2008</a>), while the prevalence rate is about 30 per 100,000 population (range 5 to 80) (<a href="./references#CD012622-bbs2-0111" title="TrisoliniM , HoneycuttA , WienerJ , LesesneS . Global economic impact of multiple sclerosis: a literature review. www.msif.org/wp‐content/uploads/2014/09/ExecSummary_English.pdf Vol. (accessed 10 October 2016). ">Trisolini 2010</a>; <a href="./references#CD012622-bbs2-0120" title="World Health Organization (WHO). Atlas: Multiple sclerosis resources in the world. www.who.int/mental_health/neurology/Atlas_MS_WEB.pdf (accessed 10 October 2016). ">WHO 2008</a>). It is more common in women (3:1 ratio) and patterns of MS presentation can vary significantly between individuals (<a href="./references#CD012622-bbs2-0046" title="CompstonA . Distribution of multiple sclerosis. In: CompstonA , EbersG , LassmannH , McDonaldI , MatthewsB , WekerleH editor(s). McAlpine’s Multiple Sclerosis. 3rd Edition. London: Churchill Livingstone, 1998:63‐100. ">Compston 1998</a>; <a href="./references#CD012622-bbs2-0048" title="DetelsR , VisscherB , HaileR , MalmgrenR , DudleyJ , CoulsonA . Multiple sclerosis and age at migration. American Journal of Epidemiology1978;108:386‐93. ">Detels 1978</a>; <a href="./references#CD012622-bbs2-0061" title="HammondSR , McLeodJG , MillingensKS , Stewart‐WynneEG , EnglishD , HollandJT , et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain1988;111:1‐25. ">Hammond 1988</a>). The exact aetiology of MS is still unclear, but it is associated with an abnormal immune response within the CNS, possibly due to an infectious agent (<a href="./references#CD012622-bbs2-0081" title="KurtzkeJF . Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983;33:1444‐52. ">Kurtzke 1983</a>). Genetic risk has also been shown in recent literature, indicating an association between HLA‐DRB1 and HLA‐DR4 genes and MS susceptibility (<a href="./references#CD012622-bbs2-0094" title="O’GormanC , LucasR , TaylorB . Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. International Journal of Molecular Sciences2012;13(9):11718–52. ">O'Gormann 2012</a>). MS is associated with long‐term physical, cognitive and behavioural disabilities, restrictions in participation, medical complications, and symptoms including pain (<a href="./references#CD012622-bbs2-0075" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036.pub2] ">Khan 2007b</a>; <a href="./references#CD012622-bbs2-0077" title="KhanF , AmatyaB , KesselringJ . Longitudinal 7‐year follow‐up of chronic pain in persons with multiple sclerosis in the community. Journal of Neurology2013;206(8):2005‐31. ">Khan 2013</a>). </p> <section id="CD012622-sec-0031"> <h3 class="title" id="CD012622-sec-0031">Description of the condition</h3> <p>According to the International Association of the Study of Pain (IASP), chronic pain is defined as "<i>pain presenting continuously or intermittently for at least three months past the normal time of healing"</i> (<a href="./references#CD012622-bbs2-0090" title="MerskeyH , BogdukN . Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd Edition. Seattle: IASP Press, 1994. ">Merskey 1994</a>). Chronic pain impacts on activities of daily living, relationships, and social roles (<a href="./references#CD012622-bbs2-0036" title="ArchibaldCJ , McGrathPJ , RitvoPG , FiskJD , BahnV , MaxnerCE , et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis. Pain1994;58:89‐93. ">Archibald 1994</a>; <a href="./references#CD012622-bbs2-0051" title="EhdeDM , GibbonsLE , ChwastiakL , BombardierCH , SullivanMD , KraftGH . Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis2003;9:606‐11. ">Ehde 2003</a>; <a href="./references#CD012622-bbs2-0074" title="KhanF , PallantJ . Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain2007;8:614‐23. ">Khan 2007a</a>; <a href="./references#CD012622-bbs2-0108" title="SvendsonKB , JensenTS , OvervadK , HansenHJ , Koch‐HendersonN , BachFW . Pain in patients with multiple sclerosis: a population based study. Archives of Neurology2003;60(8):1089‐94. ">Svendson 2003</a>; <a href="./references#CD012622-bbs2-0119" title="WarnellP . The pain experience of a multiple sclerosis population: a descriptive study. Axone1991;13:26‐8. ">Warnell 1991</a>), interferes with work (<a href="./references#CD012622-bbs2-0036" title="ArchibaldCJ , McGrathPJ , RitvoPG , FiskJD , BahnV , MaxnerCE , et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis. Pain1994;58:89‐93. ">Archibald 1994</a>), and has been associated with increased psychological impairment, such as depression (<a href="./references#CD012622-bbs2-0051" title="EhdeDM , GibbonsLE , ChwastiakL , BombardierCH , SullivanMD , KraftGH . Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis2003;9:606‐11. ">Ehde 2003</a>). Many psychosocial factors influence adjustment to chronic pain, including pain‐related beliefs, coping behaviours, family members' responses to pain behaviours (<a href="./references#CD012622-bbs2-0057" title="FordyceWE , FowlerRS , LehmanJF , DelateurBJ , SandPL , TrieschmannRB . Operant conditioning in the treatment of chronic pain. Archives of Physical Medicine and Rehabilitation1973;54:399‐408. ">Fordyce 1973</a>), psychological distress, and pain‐related disability (<a href="./references#CD012622-bbs2-0071" title="JensenMP , RomanoJM , TurnerJA , LawlerBK . Patient beliefs predict patient functioning: further support for a cognitive‐behavioral model of chronic pain. Pain1999;81:95‐104. ">Jensen 1999</a>). Chronic pain is associated with poorer general health, increased fatigue, and higher rates of healthcare utilisation (<a href="./references#CD012622-bbs2-0041" title="BlythFM , MarchLM , CousinsMJ . Chronic pain related disability and use of analgesia and health services in a Sydney community. Medical Journal of Australia2003;179:84‐7. ">Blyth 2003</a>; <a href="./references#CD012622-bbs2-0051" title="EhdeDM , GibbonsLE , ChwastiakL , BombardierCH , SullivanMD , KraftGH . Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis2003;9:606‐11. ">Ehde 2003</a>; <a href="./references#CD012622-bbs2-0085" title="MaVY , ChanL , CarruthersKJ . Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Archives of Physical Medicine and Rehabilitation2014;95(5):986‐95. ">Ma 2014</a>; <a href="./references#CD012622-bbs2-0107" title="SullivanMJL , EdgeleyK , MikailS , DehouxE . Psychological correlates of health care utilization in chronic illness. Canadian Journal of Rehabilitation1992;6:13‐21. ">Sullivan 1992</a>; <a href="./references#CD012622-bbs2-0115" title="VickreyBG , HaysRD , HarooniR , MyersLW , EllisonGW . Health related quality of life measure for multiple sclerosis. Quality of Life Research1995;4:187‐206. ">Vickrey 1995</a>;). It is a significant health problem, impacting working‐age populations and causing social disadvantage (<a href="./references#CD012622-bbs2-0041" title="BlythFM , MarchLM , CousinsMJ . Chronic pain related disability and use of analgesia and health services in a Sydney community. Medical Journal of Australia2003;179:84‐7. ">Blyth 2003</a>; <a href="./references#CD012622-bbs2-0100" title="ShahrbanianS , AuaisM , DuguetteP , AndersonK , MayoN . Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta‐analysis. Pain Research and Management2013;18(5):e94‐e100. ">Shahrbanian 2013</a>), with an estimated cost of approximately $34 billion per annum in Australia alone (<a href="./references#CD012622-bbs2-0040" title="BlythFM , MarchLM , BarnabieAJ , JormLR , WilliamsonM , CousinsMJ . Chronic pain in Australia: a prevalence study. Pain2001;89:127‐34. ">Blyth 2001</a>). </p> <p>In persons with MS (pwMS), symptoms such as headache and neuropathic extremity pain, back pain, painful spasms and Lhermitte's phenomenon are common and trigeminal neuropathic pain is least common. However, there is no confirmed prevalence and/or incidence rate of these symptoms in the literature. </p> <p>Pain can be a significant problem for a substantial proportion of pwMS (<a href="./references#CD012622-bbs2-0052" title="EhdeDM , OsborneTL , JensenMP . Chronic pain in persons with multiple sclerosis. Physical Medicine and Rehabilitation Clinics North America2005;14:503‐12. ">Ehde 2005</a>; <a href="./references#CD012622-bbs2-0074" title="KhanF , PallantJ . Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain2007;8:614‐23. ">Khan 2007a</a>). It is estimated that 42% to 90% pwMS experience pain (<a href="./references#CD012622-bbs2-0045" title="CliffordDB , TrotterJL . Pain in multiple sclerosis. Archives of Neurology1984;41(12):1270‐2. ">Clifford 1984</a>; <a href="./references#CD012622-bbs2-0064" title="Heckman‐StoneC , StoneC . Pain management techniques used by patients with multiple sclerosis. Journal of Pain2001;2:205‐8. ">Heckman‐Stone 2001</a>; <a href="./references#CD012622-bbs2-0092" title="MoulinDE , FoleyKM , EbersGC . Pain syndromes in multiple sclerosis. Neurology1988;38(12):1830‐4. ">Moulin 1988</a>; <a href="./references#CD012622-bbs2-0105" title="StenagerE , KnudsenL , JensenK . Acute and chronic pain syndrome in multiple sclerosis. Acta Neurologica Scandinavica1991;84(3):197‐200. ">Stenager 1991</a>; <a href="./references#CD012622-bbs2-0114" title="VermoteR , KetelaerP , CartonH . A prospective study using the McGill pain questionnaire. Clinical Neurology and Neurosurgery1986;88(2):87‐93. ">Vermote 1986</a>), and occurs at all stages of the disease. MS‐related pain can cause both acute and chronic symptoms. It is associated with active inflammation from the MS process itself (central neuropathic pain such as trigeminal neuropathic pain) and from MS‐related complications (tonic spasms, headaches and musculoskeletal problems such as posture and gait anomalies) (<a href="./references#CD012622-bbs2-0076" title="KhanF , PallantJF , AmatyaB , YoungK , GibsonS . Cognitive‐behavioral classifications of chronic pain in persons with multiple sclerosis. International Journal of Rehabilitation Research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation2011;34:235‐42. ">Khan 2011</a>). Pain is reported as one of the most severe symptoms in 8% to 32% of pwMS (<a href="./references#CD012622-bbs2-0033" title="AlbertML . Treatment of pain in multiple sclerosis ‐ preliminary report. New England Journal of Medicine1969;280(25):1395. ">Albert 1969</a>; <a href="./references#CD012622-bbs2-0102" title="ShibasakiH , KuroiwaY . Painful tonic seizure in multiple sclerosis. Archives of Neurology1974;30:47‐51. ">Shibasaki 1974</a>; <a href="./references#CD012622-bbs2-0105" title="StenagerE , KnudsenL , JensenK . Acute and chronic pain syndrome in multiple sclerosis. Acta Neurologica Scandinavica1991;84(3):197‐200. ">Stenager 1991</a>) and it often co‐exists as a mix of acute, paroxysmal and chronic pain in the same or various parts of the body (<a href="./references#CD012622-bbs2-0056" title="FoleyPL , VesterinenHM , LairdBJ , SenaES , ColvinLA , ChandranS , et al. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta‐analysis. Pain2013;154(5):632‐42. ">Foley 2013</a>; <a href="./references#CD012622-bbs2-0116" title="VonKorffM , OrmelJ , KeefeFJ , DworkinSF . Grading the severity of chronic pain. Pain1992;50:130‐49. ">Von Korff 1992</a>). </p> <p>Based on the underlying pathophysiological mechanism, MS‐related pain can be classified into 5 categories (<a href="./references#CD012622-bbs2-0112" title="TruiniA , BarbantiP , PozzilliC , CruccuG . A mechanism‐based classification of pain in multiple sclerosis. Journal of Neurology2013;260(2):351‐67. ">Truini 2013</a>). </p> <p> <ul id="CD012622-list-0001"> <li> <p><i>Neuropathic pain</i>, defined by the IASP (<a href="./references#CD012622-bbs2-0090" title="MerskeyH , BogdukN . Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. 2nd Edition. Seattle: IASP Press, 1994. ">Merskey 1994</a>) as pain arising directly from a lesion or disease affecting the somatosensory system (<a href="./references#CD012622-bbs2-0110" title="TreedeRD , JensenTS , CampbellJN , CruccuG , DostrovskyJO , GriffinJW , et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology2008;70:1630‐5. ">Treede 2008</a>), which can consist of persistent extremity pain and dysaesthesia, trigeminal neuropathic pain, and Lhermitte's phenomenon (defined as a transient sensation related to neck movements felt in the back of the neck, lower back and other parts of the body) (<a href="./references#CD012622-bbs2-0032" title="Al‐ArajiAH , OgerJ . Reappraisal of Lhemitte's sign in multiple sclerosis. Multiple Sclerosis2005;11:398‐402. ">Al‐Araji 2005</a>). </p> </li> <li> <p><i>Nociceptive pain</i>, either inflammatory or non‐inflammatory, includes musculoskeletal and low back pain that may be posture‐related, optic neuritis (<a href="./references#CD012622-bbs2-0112" title="TruiniA , BarbantiP , PozzilliC , CruccuG . A mechanism‐based classification of pain in multiple sclerosis. Journal of Neurology2013;260(2):351‐67. ">Truini 2013</a>), headaches and treatment‐induced pain. </p> </li> <li> <p><i>Psychogenic pain</i> is difficult to define and refers to somatoform pain associated with psychiatric conditions such as depression and anxiety or pain behaviours that have evolved in patients with chronic refractory pain. </p> </li> <li> <p><i>Idiopathic pain</i> includes conditions which are either poorly understood or controversial such as fibromyalgia, interstitial cystitis and atypical facial pain. </p> </li> <li> <p><i>Mixed pain</i> encompasses a heterogeneous group of pain with different pathophysiological mechanisms caused by MS (such as painful tonic spasms which may involve unilateral, bilateral or stereotyped involuntary muscle spasms and spasticity pain). </p> </li> </ul> </p> </section> <section id="CD012622-sec-0032"> <h3 class="title" id="CD012622-sec-0032">Description of the intervention</h3> <p>In general, pain in MS is treated with pharmacological agents (<a href="./references#CD012622-bbs2-0047" title="CutterNC , ScottDD , JohnsonJC , WhiteneckG . Gabapentin effect on spasticity in multiple sclerosis: a placebo‐controlled, randomised trial. Archives of Physical Medicine and Rehabilitation2000;81:164‐9. ">Cutter 2000</a>; <a href="./references#CD012622-bbs2-0097" title="RogDJ , NurmikkoTJ , FriedeT , YoungCA . Randomized, controlled trial of cannabis‐based medicine in central pain in multiple sclerosis. Neurology2005;65(6):812‐9. ">Rog 2005</a>; <a href="./references#CD012622-bbs2-0098" title="RossiS , MataluniG , CodecaC , FioreS , ButtariF , MusellaA , et al. Effects of levetiracem on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo‐controlled study. European Journal of Neurology2009;16:360‐6. ">Rossi 2009</a>; <a href="./references#CD012622-bbs2-0101" title="ShakespeareD , BogglidM , YoungCA . Anti‐spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD001332] ">Shakespeare 2003</a>) and non‐pharmacological modalities, or a combination of both (<a href="./references#CD012622-bbs2-0099" title="SaifuddinE , NgL , AmatyaB , KhanF . Chronic pain in multiple sclerosis: an overview. American Journal of Internal Medicine2014;2(2):20‐5. ">Saifuddin 2014</a>). For the purpose of this review, non‐pharmacological therapies or interventions refer to <i>treatments and management strategies that do not involve the use of medications or surgery</i> (<a href="./references#CD012622-bbs2-0034" title="AmatyaB , KhanF , LaMantiaL , DemetriosM , WadeDT . Non pharmacological interventions for spasticity in multiple sclerosis. Cochrane Database of Systematic Reviews2013, Issue 2. [DOI: 10.1002/14651858.CD009974.pub2] ">Amatya 2013</a>; <a href="./references#CD012622-bbs2-0043" title="BoldtI , Eriks‐HooglandI , BrinkhofMW , BieRA , VonElmE . Non‐pharmacological interventions for chronic pain in people with spinal cord injury. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD009177.pub2] ">Boldt 2011</a>). A wide range of non‐pharmacological interventions have been trialled for the management of pain in pwMS. Previous studies (<a href="./references#CD012622-bbs2-0064" title="Heckman‐StoneC , StoneC . Pain management techniques used by patients with multiple sclerosis. Journal of Pain2001;2:205‐8. ">Heckman‐Stone 2001</a>; <a href="./references#CD012622-bbs2-0074" title="KhanF , PallantJ . Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain2007;8:614‐23. ">Khan 2007a</a>; <a href="./references#CD012622-bbs2-0077" title="KhanF , AmatyaB , KesselringJ . Longitudinal 7‐year follow‐up of chronic pain in persons with multiple sclerosis in the community. Journal of Neurology2013;206(8):2005‐31. ">Khan 2013</a>) have found that MS patients in the community setting frequently use a wide variety of non‐pharmacological techniques, which include passive strategies such as transcutaneous electrical nerve stimulation (TENS), heat and/or cold therapy, supportive braces, alternative therapies; and active strategies such as exercise, biofeedback, relaxation, distraction, and psychosocial interventions (<a href="./references#CD012622-bbs2-0074" title="KhanF , PallantJ . Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain2007;8:614‐23. ">Khan 2007a</a>; <a href="./references#CD012622-bbs2-0077" title="KhanF , AmatyaB , KesselringJ . Longitudinal 7‐year follow‐up of chronic pain in persons with multiple sclerosis in the community. Journal of Neurology2013;206(8):2005‐31. ">Khan 2013</a>). The availability of a variety of therapeutic techniques was postulated to empower patients with greater control of their pain management and possibly allow more optimal adaptation to a progressive condition. </p> </section> <section id="CD012622-sec-0033"> <h3 class="title" id="CD012622-sec-0033">How the intervention might work</h3> <p>The underlying mechanisms of pain in MS are unclear and have been linked with the differentiation and disinhibition of central and peripheral pathways, CNS lesions causing hyperexcitability, and increased neuronal (nerve cell) activity at the site of the lesion in the spinal cord (<a href="./references#CD012622-bbs2-0039" title="BericA . Central pain and dysesthesia syndrome. Neurolgy Clinics1998;16(4):899‐918. ">Beric 1998</a>; <a href="./references#CD012622-bbs2-0042" title="BoivieJ . Central pain. In: WallPD , MelzackR editor(s). Textbook of Pain. New York: Churchill Livingstone, 1999:879‐914. ">Boivie 1999</a>; <a href="./references#CD012622-bbs2-0062" title="HansBC , WillisWD , HulseboschCE . Temporal plasticity of dorsal horn somatosensory neurons after acute and chronic spinal cord hemisection in rat. Brain Research2003;970:238‐41. ">Hans 2003</a>; <a href="./references#CD012622-bbs2-0082" title="LalkhenAG , BedfordJP , DwyerAD . Pain associated with multiple sclerosis: epidemiology, classification and management. British Journal of Neuroscience Nursing2012;8(5):267‐74. ">Lalkhen 2012</a>). Chronic pain may develop and evolve as a maladaptive response involving neuronal pathways that are affected by internal and environmental influences in a complex interplay that is then perceived in a highly subjective fashion by each individual. It can arise both centrally and peripherally, and may be triggered by either a noxious or a non‐noxious stimulus or can also occur spontaneously in the absence of any definable trigger (<a href="./references#CD012622-bbs2-0042" title="BoivieJ . Central pain. In: WallPD , MelzackR editor(s). Textbook of Pain. New York: Churchill Livingstone, 1999:879‐914. ">Boivie 1999</a>; <a href="./references#CD012622-bbs2-0070" title="JensenMP , TurnerJA , RomanoJM , LawlerBK , BrianK . Relationship of pain specific beliefs to chronic pain adjustment. Pain1994;57:301‐9. ">Jensen 1994</a>; <a href="./references#CD012622-bbs2-0071" title="JensenMP , RomanoJM , TurnerJA , LawlerBK . Patient beliefs predict patient functioning: further support for a cognitive‐behavioral model of chronic pain. Pain1999;81:95‐104. ">Jensen 1999</a>;). Due to this heterogeneity of chronic pain aetiology amongst pwMS, modalities that act at different sites along the pain processing pathway may have variable degrees of effectiveness (<a href="./references#CD012622-bbs2-0076" title="KhanF , PallantJF , AmatyaB , YoungK , GibsonS . Cognitive‐behavioral classifications of chronic pain in persons with multiple sclerosis. International Journal of Rehabilitation Research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation2011;34:235‐42. ">Khan 2011</a>; <a href="./references#CD012622-bbs2-0082" title="LalkhenAG , BedfordJP , DwyerAD . Pain associated with multiple sclerosis: epidemiology, classification and management. British Journal of Neuroscience Nursing2012;8(5):267‐74. ">Lalkhen 2012</a>). </p> <p>Although the exact role of physiological deconditioning in nociceptive input or perceived pain is not well defined, it is clear that improvement in overall physical function is linked with improvement in psychosocial function and mood (<a href="./references#CD012622-bbs2-0103" title="SimmondsMJ , KumarS , LecheltE . Psychosocial factors in disabling low back pain: causes or consequences. Disability and Rehabilitation1996;18(4):161‐8. ">Simmonds 1996</a>), which in turn influences levels of pain. There is evidence that motor control and proprioceptive efficiency are altered, balance is compromised, and reaction times are slower in persons with pain (<a href="./references#CD012622-bbs2-0063" title="HardingVR , SimmondsMJ , WatsonPJ . IASP Clinical Update. Vol. 6, IASP, 1998. ">Harding 1998</a>). TENS and acupuncture attempt to modulate pain from the periphery, whilst dorsal column stimulation intercepts the nociceptive signal at the level of the spinal cord. Cognitive behavioural therapy and other psychotherapies, on the other hand, utilise strategies that modify perception and cognition to enact a positive change in behaviour and mood. </p> </section> <section id="CD012622-sec-0034"> <h3 class="title" id="CD012622-sec-0034">Why it is important to do this review</h3> <p>Pain is prevalent in pwMS and tends to increase over time, due to the disease process itself and from MS‐related complications, and is associated with a great interference with pwMS' daily life activities (<a href="./references#CD012622-bbs2-0077" title="KhanF , AmatyaB , KesselringJ . Longitudinal 7‐year follow‐up of chronic pain in persons with multiple sclerosis in the community. Journal of Neurology2013;206(8):2005‐31. ">Khan 2013</a>). Several studies have demonstrated that those with higher pain grades reported more disability and healthcare visits, and lower quality of life (QoL) (<a href="./references#CD012622-bbs2-0074" title="KhanF , PallantJ . Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. Journal of Pain2007;8:614‐23. ">Khan 2007a</a>). Non‐pharmacological therapies are widely used, both in hospital and ambulatory/mobility settings, to improve pain control, coping ability, daily function and QoL in pwMS. Chronic pain is found to be amenable to multidisciplinary rehabilitation management (<a href="./references#CD012622-bbs2-0054" title="FinlaysonM , PreissnerK , ChoC , PlowM . Randomized trial of a teleconference‐delivered fatigue management program for people with multiple sclerosis. Multiple Sclerosis2011;17(9):1130‐40. ">Finlayson 2011</a>; <a href="./references#CD012622-bbs2-0073" title="KarjalainenKA , MalmivaaraA , VanTulderMW , RoineR , JauhiainenM , HurriH , et al. Multidisciplinary biopsychosocial rehabilitation for sub‐acute low‐back pain among working age adults. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD002193] ">Karjalainen 2003</a>; <a href="./references#CD012622-bbs2-0075" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036.pub2] ">Khan 2007b</a>; <a href="./references#CD012622-bbs2-0078" title="KraftGH , CuiJY . Multiple sclerosis. In: DelisaJA editor(s). Physical Medicine &amp; Rehabilitation: Principles &amp; Practice. Philadelphia: Lipincott Williams &amp; Wilkins, 2005:1753‐69. ">Kraft 2005</a>; <a href="./references#CD012622-bbs2-0099" title="SaifuddinE , NgL , AmatyaB , KhanF . Chronic pain in multiple sclerosis: an overview. American Journal of Internal Medicine2014;2(2):20‐5. ">Saifuddin 2014</a>). Psychological interventions have shown potential beneficial impact on pwMS, including the management of symptoms such as pain and fatigue (<a href="./references#CD012622-bbs2-0109" title="ThomasPW , ThomasS , HillierC , GalvinK , BakerR . Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004431.pub2] ">Thomas 2006</a>). Further, TENS is commonly trialled for chronic low back pain in pwMS and hypoalgesic effects (<a href="./references#CD012622-bbs2-0031" title="Al‐SmadiJ , WarkeK , WilsonI , CrampAF , NobleG , WalshDM , et al. A pilot investigation of the hypoalgesic effects of transcutaneous electrical stimulation upon lower back in people with multiple sclerosis. Clinical Rehabilitation2003;17(7):742‐9. ">Al Smadi 2003</a>). Similarly, anodal transcranial Direct Current Stimulation (tDCS) has demonstrated effectiveness in reducing central chronic pain in the MS population (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>). To our knowledge, there is only one published systematic review on non‐pharmacological management in pwMS (<a href="./references#CD012622-bbs2-0069" title="JawaharR , OhU , YangS , LapaneKL . Alternative approach: a systematic review of non‐pharmacological non‐spastic and non‐trigeminal pain management in multiple sclerosis. European Journal of Physical and Rehabilitation Medicine2014;50(5):567‐77. ">Jawahar 2014</a>), which excluded non‐spastic and non‐trigeminal pain. This review identified the main categories of non‐pharmacological interventions, which included education, electrical and physical therapy. The reviewers found that low‐frequency TENS had the greatest reduction in pain scores (<a href="./references#CD012622-bbs2-0069" title="JawaharR , OhU , YangS , LapaneKL . Alternative approach: a systematic review of non‐pharmacological non‐spastic and non‐trigeminal pain management in multiple sclerosis. European Journal of Physical and Rehabilitation Medicine2014;50(5):567‐77. ">Jawahar 2014</a>). This systematic review did have several limitations, including inclusion of non‐randomised clinical trials and pilot studies, and exclusion of various non‐pharmacological interventions, such acupuncture, massage therapy, thermotherapy, electrical therapy such as transmagnetic stimulation (TMS) and tDCS<b>.</b> An updated systematic evaluation of the existing evidence is therefore needed to determine the effectiveness and safety of all non‐pharmacological modalities to provide treating clinicians clear guidance for clinical decision‐making for appropriate pain management in pwMS. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012622-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012622-sec-0035"></div> <p>This review aimed to investigate the effectiveness and safety of non‐pharmacological therapies for the management of chronic pain in persons with multiple sclerosis (pwMS). </p> <p>Specific questions to be addressed by this review include the following.</p> <p> <ul id="CD012622-list-0002"> <li> <p>Are non‐pharmacological interventions (unidisciplinary or multidisciplinary, or both, rehabilitation interventions) effective in reducing chronic pain in pwMS? </p> </li> <li> <p>What type of non‐pharmacological interventions (unidisciplinary or multidisciplinary, or both, rehabilitation interventions) are effective (least and most effective) and in what setting, in reducing chronic pain in pwMS? </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012622-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012622-sec-0036"></div> <section id="CD012622-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012622-sec-0038"> <h4 class="title">Types of studies</h4> <p>All published randomised controlled trials (RCTs), including cross‐over studies that compared non‐pharmacological interventions with no treatment, sham and usual care, for managing chronic pain in pwMS were included. Clinical controlled trials (CCTs) were eligible for inclusion, but none were identified. We included only trials with a full journal publication, with a minimum treatment period of two weeks or more, with greater attention given to studies with a duration of eight weeks or greater. We excluded studies of experimental pain, observational studies, case reports, and clinical observations. </p> </section> <section id="CD012622-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included trials if the study population had a confirmed diagnosis of MS based on standard criteria (<a href="./references#CD012622-bbs2-0087" title="McDonaldWI , CompstonA , EdanG , GoodkinD , HartungHP , LublinFD , et al. Recommended diagnostic criteria for MS: guidelines from the international panel on the diagnosis of MS. Annals of Neurology2001;59(1):121‐7. ">McDonald 2001</a>) and participants were aged 18 years and older with chronic pain. All studies with participants with 'chronic pain' or participants suffering from pain longer than three months were included, irrespective of the use of varying definitions for chronicity of pain. We included studies that recruited participants with the minimum levels of pain on visual analogue scale (VAS) of 3/10. Studies including participants with other diagnoses were excluded unless individual data for the pwMS could be obtained either from the published results or through contact with authors. </p> </section> <section id="CD012622-sec-0040"> <h4 class="title">Types of interventions</h4> <p>All non‐pharmacological interventions to manage chronic pain in pwMS delivered in any settings (inpatient, outpatient, community, or home‐based) were included. </p> <p> <ul id="CD012622-list-0003"> <li> <p>Unidisciplinary: physiotherapy, occupational therapy, and individual treatment modalities, thermotherapy such as heat and cold application, psychological and behavioural therapies including cognitive behavioural therapy and hypnosis, relaxation training, yoga, massage, chiropractic manipulation, acupuncture, other alternative and complementary therapies, TMS, TENS, tDCS, dorsal root entry zone (DREZ) lesioning and others. </p> </li> <li> <p>Multidisciplinary rehabilitation programmes, defined as any co‐ordinated therapy programme delivered by two or more disciplines (occupational therapy, physiotherapy, exercise physiology, orthotics, other allied health and nursing) in conjunction with medical input (neurologist or rehabilitation medicine physician) that aims to achieve patient‐centred goals related to reducing chronic pain. </p> </li> </ul> </p> <p>Control interventions that are likely used for comparison with the above mentioned interventions include no treatment, sham and usual care. </p> </section> <section id="CD012622-sec-0041"> <h4 class="title">Types of outcome measures</h4> <p>Diverse outcomes were expected, given the varied presentations of pain‐related problems and goals of treatment related to pain severity in MS. </p> <section id="CD012622-sec-0042"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome determined whether the intervention produces reduction in pain measured by validated measurers, such as a visual analogue scale (VAS) or numerical rating scale (NRS) (<a href="./references#CD012622-bbs2-0072" title="JensenMP , KarolyP . Self‐report scales and procedures for assessing pain in adults. In: TurkDC , MelzackR editor(s). Handbook of Pain Assessment. USA: Guilford Press, 2001:15–34. ">Jensen 2001</a>), Likert scale such as the Patient’s Global Impression of Change (PGIC, <a href="./references#CD012622-bbs2-0068" title="HurstH , BoltonJ . Assessing the clinical significance of change scores recorded on subjective outcome measures. Journal of Manipulative and Physiological Therapeutics2004;27:26‐35. ">Hurst 2004</a>), or Clinical Global Impression of Change (CGIC, <a href="./references#CD012622-bbs2-0121" title="ZaiderTI , HeimbergRG , FrescoDM , SchneierFR , LiebowitzMR . Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychological Medicine2003;33(4):611‐22. ">Zaider 2003</a>), or specific pain scales such as the McGill Pain Questionnaire (MPQ, <a href="./references#CD012622-bbs2-0088" title="MelzackR . The McGill Pain Questionnaire: major properties and scoring methods. Pain1975;1:277‐99. ">Melzack 1975</a>), Short Form McGill Pain Questionnaire (SFMPQ, <a href="./references#CD012622-bbs2-0089" title="MelzackR . The short‐form McGill Pain Questionnaire. Pain1987;30:191‐7. ">Melzack 1987</a>), or Brief Pain Inventory (BPI, <a href="./references#CD012622-bbs2-0044" title="CleelandC . Measurement of pain by subjective report. Advances in Pain Research and Therapy: Issues in Pain Measurement. Vol. 12, New York: Raven Press, 1989:391‐403. ">Cleeland 1989</a>), and others (subjective or objective). We used the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) (<a href="./references#CD012622-bbs2-0049" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Pain2008;9(2):105‐21. ">Dworkin 2008</a>) criteria, defined as: </p> <p> <ul id="CD012622-list-0004"> <li> <p>at least 30% pain relief over baseline (moderate);</p> </li> <li> <p>at least 50% pain relief over baseline (substantial);</p> </li> <li> <p>much improved on Patient Global Impression of Change Scale (PGIC; moderate);</p> </li> <li> <p>very much improved on PGIC (substantial).</p> </li> </ul> </p> </section> <section id="CD012622-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p>Due to the multidimensional model of pain, we included secondary outcomes determining whether the change in pain by the intervention affects the other specific outcome(s) measured by validated tools, which included: </p> <p> <ul id="CD012622-list-0005"> <li> <p>other symptoms or impairments, such as spasticity, fatigue, e.g. Multiple Sclerosis Spasticity Scale (MSSS‐88, <a href="./references#CD012622-bbs2-0067" title="HobartJC , RiaziA , ThompsonAJ , StylesIM , IngramW , VickeryPJ , et al. Getting the measure of spasticity in multiple sclerosis: The Multiple Sclerosis Spasticity Scale (MSSS‐88). Brain2006;129:224‐34. ">Hobart 2006</a>); Modified Ashworth Scale (MAS, <a href="./references#CD012622-bbs2-0035" title="AnsariNN , NaghdiS , HassonS , FakhariZ , MashayekhiM , HerasiM . Assessing the reliability of the Modified Ashworth Scale between two physiotherapists in adult patients with hemiplegia. NeuroRehabilitation2009;25(4):235‐40. ">Ansari 2009</a>); Fatigue Impacts Scale (FIS, <a href="./references#CD012622-bbs2-0055" title="FiskJD , RitvoPG , RossL , HaaseDA , MarrieTJ , SchlechWF . Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Diseases1994;18:S79‐83. ">Fisk 1994</a>); Modified Fatigue Impact Scale (MFIS,<a href="./references#CD012622-bbs2-0083" title="LarsonR . Psychometric properties of the modified fatigue impact scale. International Journal of MS Care2013;15(1):15‐20. ">Larson 2013</a>); Fatigue Severity Score (FSS,<a href="./references#CD012622-bbs2-0080" title="KruppLB , LaRoccaNG , Muir‐NashJ , SteinbergAD . The Fatigue Severity Scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology1989;46(10):1121‐3. ">Krupp 1989</a>); </p> </li> <li> <p>functional activity, e.g. Functional Independence Measure (FIM, <a href="./references#CD012622-bbs2-0060" title="GrangerCV . The emerging science of functional assessment: our tool for outcomes analysis. Archives of Physical Medicine and Rehabilitation1998;79:235‐40. ">Granger 1998</a>); Barthel index (BI, <a href="./references#CD012622-bbs2-0086" title="MahoneyFI , BarthelD . Functional evaluation: the Barthel Index. Maryland State Medical Journal1965;14:56‐61. ">Mahoney 1965</a>); Rowland Morris Disability Questionnaire (RMDQ, <a href="./references#CD012622-bbs2-0106" title="StevensM , LinL , MaherC . The Roland Morris Disability Questionnaire. Journal of Physiotherapy2016;62(2):116. ">Stevens 2016</a>); </p> </li> <li> <p>psychosocial outcomes, e.g. Beck Depression Inventory (BDI, <a href="./references#CD012622-bbs2-0037" title="BeckAT , WardCH , MendelsonM , MockJ , ErbaughJ . An inventory for measuring depression. Archives of General Psychiatry1961;4:561‐71. ">Beck 1961</a>); Depression, Stress and Anxiety Scale (DASS, <a href="./references#CD012622-bbs2-0084" title="LovibondSH , LovibondPF . Manual for the depression anxiety stress scales. trove.nla.gov.au/work/30421447 (accessed 10/10/2016). ">Lovibond 1995</a>); Hospital Anxiety Depression Scale (HADS, <a href="./references#CD012622-bbs2-0104" title="SnaithR . Hospital Anxiety and Depression scale (HADS). Health and quality of life outcomes2003;1(1):29. ">Snaith 2003</a>); Patient Health Questionnaire 9 (PHQ‐9, <a href="./references#CD012622-bbs2-0079" title="KroenkeK , SpitzerRL , WilliamsJB . Patient Health Questionnaire (PHQ‐9). Journal of General Internal Medicine2001;16(9):606‐13. ">Kroenke 2001</a>); </p> </li> <li> <p>restriction in participation/impact on carers, e.g. Caregiver Strain Index (CSI, <a href="./references#CD012622-bbs2-0096" title="RobinsonBC . Validation of a Caregiver Strain Index (CSI). Journal of Gerontology1983;38(3):344‐8. ">Robinson 1983</a>); </p> </li> <li> <p>vocational outcomes, e.g. Work Instability Scale (WIS, <a href="./references#CD012622-bbs2-0058" title="GilworthG , ChamberlainMA , HarveyA . Development of a work instability scale for rheumatoid arthritis. Arthritis and Rheumatism2003;49:349‐54. ">Gilworth 2003</a>); </p> </li> <li> <p>quality of life, e.g. Multiple Sclerosis Quality of Life (MSQOL54, <a href="./references#CD012622-bbs2-0115" title="VickreyBG , HaysRD , HarooniR , MyersLW , EllisonGW . Health related quality of life measure for multiple sclerosis. Quality of Life Research1995;4:187‐206. ">Vickrey 1995</a>); Short Form Health Survey (SF‐36, <a href="./references#CD012622-bbs2-0117" title="WareJEJr . SF‐36 health survey update. Spine2000;25(24):3130‐9. ">Ware 2000</a>); Leeds Multiple Sclerosis Quality of Life (LMSQOL, <a href="./references#CD012622-bbs2-0053" title="EnsariI , MotlR , McAuleyE . Structural and construct validity of the Leeds Multiple Sclerosis Quality of Life scale. Quality of Life Research2016;25(6):1605‐11. ">Ensari 2016</a>); Multiple Sclerosis Impact Scale (MSIS‐29, <a href="./references#CD012622-bbs2-0066" title="HobartJ . The Multiple Sclerosis Impact Scale (MSIS‐29): a new patient‐based outcome measure. Brain2001;124(5):962‐73. ">Hobart 2001</a>); </p> </li> <li> <p>withdrawals, due to lack of efficacy;</p> </li> <li> <p>outcomes that reflect utilisation of healthcare resources and associated cost (reported, where possible); </p> </li> <li> <p>participants experiencing any adverse effects;</p> </li> <li> <p>participants experiencing any serious adverse effects, which include any untoward medical occurrence or effect that results in death, is life‐threatening, requires hospitalisation or prolongation of existing hospital stay, results in persistent or significant disability or incapacity, congenital anomaly or birth defect, that may jeopardise the person or may require intervention. </p> </li> </ul> </p> <section id="CD012622-sec-0044"> <h6 class="title">Timing of outcome measures</h6> <p>We divided outcome time points into short term (up to three months) and long term (greater than three months) from the start of the intervention. </p> </section> </section> </section> </section> <section id="CD012622-sec-0045"> <h3 class="title">Search methods for identification of studies</h3> <p>We considered articles in all languages with a view to translation, if necessary.</p> <section id="CD012622-sec-0046"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist searched (up to 10 December 2017) the Trials Register of the Cochrane MS and Rare Diseases of the CNS Group, which, among other sources, contains trials from: </p> <p> <ul id="CD012622-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (2017, issue 12);</p> </li> <li> <p>MEDLINE (PubMed) (1966 to 10 December 2017);</p> </li> <li> <p>Embase (Embase.com) (1974 10 December 2017);</p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCOhost) (1981 to 10 December 2017); </p> </li> <li> <p>Latin American and Caribbean Health Science Information Database (LILACS) (Bireme) (1982 to 10 December 2017); </p> </li> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">https://clinicaltrials.gov/</a>); and </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>). </p> </li> </ul> </p> <p>The keywords that were used to search for trials for this review are listed in <a href="./appendices#CD012622-sec-0090">Appendix 2</a>. </p> <p>Information on the Group's Trials Register and details of search strategies used to identify trials can be found in the 'Specialised Register' section within the Cochrane MS and Rare Diseases of the Central Nervous System Group's <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/MS/frame.html" target="_blank">module</a>. </p> <p>In addition we searched the following databases:</p> <p> <ul id="CD012622-list-0007"> <li> <p>PsycINFO (1980 to 10 December 2017), (<a href="./appendices#CD012622-sec-0091">Appendix 3</a>); </p> </li> <li> <p>Allied and Complementary Medicine Database (AMED) (1985 to 10 December 2017) (<a href="./appendices#CD012622-sec-0092">Appendix 4</a>); and </p> </li> <li> <p>MANTIS/Ovid (for most recent data available) (<a href="./appendices#CD012622-sec-0093">Appendix 5</a>). </p> </li> </ul> </p> </section> <section id="CD012622-sec-0047"> <h4 class="title">Searching other resources</h4> <p>We conducted an expanded search to identify articles potentially missed through the database searches and articles from ‘grey literature’. These were: </p> <p> <ul id="CD012622-list-0008"> <li> <p>related articles feature (via PubMed);</p> </li> <li> <p>ProQuest Dissertations and Theses;</p> </li> <li> <p>Web of Science for citation of key authors;</p> </li> <li> <p>SIGLE (System for Information on Grey Literature in Europe); and</p> </li> <li> <p>contact authors and researchers active in this field.</p> </li> </ul> </p> </section> </section> <section id="CD012622-sec-0048"> <h3 class="title" id="CD012622-sec-0048">Data collection and analysis</h3> <section id="CD012622-sec-0049"> <h4 class="title">Selection of studies</h4> <p>Two review authors (BA, JY) independently screened and short‐listed all abstracts and titles of studies identified by the search strategy for appropriateness based on the selection criteria. The same review authors (BA, JY) independently reviewed the abstract of each study from the short list of potentially appropriate studies for inclusion or exclusion. The full text of the article was obtained to determine if the study met the inclusion/exclusion criteria. Articles assessed in full text that did not meet the inclusion criteria were listed in the <a href="./references#CD012622-sec-0102" title="">Characteristics of excluded studies</a> with the reasons for exclusion. If no consensus was met about the possible inclusion/exclusion of any individual study, a final consensus decision was made by discussion with the third author (FK). Review authors were not masked to the name(s) of the author(s), institution(s) or publication source at any level of the review. Further information was sought about the method of randomisation and other methodological issues, if required. We excluded studies with fatal flaws (for instance, withdrawals by more than 40% of the participants, or nearly total non‐adherence to the protocol, or very poor or non‐adjusted comparability in the baseline criteria). </p> </section> <section id="CD012622-sec-0050"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (BA, JY) independently extracted the data from the included trials using a standardised form and entered the data into the RevMan software (<a href="./references#CD012622-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), which included: </p> <p> <ul id="CD012622-list-0009"> <li> <p>year of publication, year the study was undertaken, and geographical location of the study; </p> </li> <li> <p>number of participants included, their age, gender, and type of MS;</p> </li> <li> <p>information about the type of pain (neuropathic/nociceptive) that is targeted by the study intervention; </p> </li> <li> <p>type of study intervention and treatment duration;</p> </li> <li> <p>information about the control intervention(s);</p> </li> <li> <p>duration of the study recruitment and follow‐up time;</p> </li> <li> <p>information about adverse events;</p> </li> <li> <p>information about withdrawals;</p> </li> <li> <p>information whether the study was specifically designed to measure pain in MS;</p> </li> <li> <p>information about study quality; and</p> </li> <li> <p>measures of treatment effect (outcome measures).</p> </li> </ul> </p> <p>A final check was made by a third review author (FK). To summarise all data on reduction in pain, we used the benchmarks of the IMMPACT recommendations for the evaluation of reduction in pain (<a href="./references#CD012622-bbs2-0049" title="DworkinRH , TurkDC , WyrwichKW , BeatonD , CleelandCS , FarrarJT , et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Pain2008;9(2):105‐21. ">Dworkin 2008</a>). We summarised all studies that met the inclusion criteria in the <a href="./references#CD012622-sec-0101" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD012622-sec-0051"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (BA, JY) independently assessed the methodological quality of the included studies using the 'Risk of bias' tool outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012622-bbs2-0065" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Higgins 2011</a>). We assessed the following for each study: </p> <p> <ul id="CD012622-list-0010"> <li> <p><i>Random sequence generation</i> (selection bias): we assessed the method used to generate the allocation sequence as: low risk of bias (any truly random process, random number table, computer random generator) and unclear risk of bias (when the method is not clearly stated). We excluded studies with a non‐random process. </p> </li> <li> <p><i>Allocation concealment</i> (selection bias): we assessed method used to conceal the allocation to interventions prior to assignment determines whether the intervention allocation could have been foreseen in advance, during recruitment, or changed after assignment. We assessed methods as low risk of bias (telephone or central randomisation; consecutively numbered, sealed, opaque envelopes) or unclear risk of bias (when method is not clearly stated). </p> </li> <li> <p><i>Blinding of participants and personnel</i> (performance bias): we assessed the methods used to blind study participants, personnel. We assessed methods as low risk of bias (study states it was blinded and described the method used to achieve the blinding) and unclear risk of bias (study stated it was blinded but did not provide adequate description of how this was achieved). </p> </li> <li> <p><i>Blinding of outcome assessment</i> (detection bias): we assessed the methods used to blind the allocated interventions by outcome assessors.We assessed methods as low risk of bias (study states blinding of outcome assessments ensured) or unclear risk of bias (when method is not clearly stated) and high risk (no blinding of outcome assessment) </p> </li> <li> <p><i>Incomplete outcome data</i> (attrition bias): we assessed the methods used to deal with incomplete data as low risk of bias (fewer than 10% of participants did not complete the study or used 'baseline observation carried forward' analysis or both), unclear risk of bias (used 'last observation carried forward' analysis) or high risk of bias (used 'completer' analysis). </p> </li> <li> <p><i>Selective reporting</i> (reporting bias): we assessed the methods used to report outcomes and selective reporting. We assessed methods as low risk of bias (all of the study's prespecified outcomes and protocol is available), unclear risk (insufficient information) or high risk (not all of the study's prespecified outcomes is reported). </p> </li> <li> <p><i>Other bias: w</i>e assessed other bias as low risk (free of other sources of bias), unclear risk (insufficient information) or high risk (potential source of bias). </p> </li> </ul> </p> <p>Any disagreements or lack of consensus was resolved by the third review author (FK).</p> </section> <section id="CD012622-sec-0052"> <h4 class="title">Measures of treatment effect</h4> <p>All quantitative data were entered and analysed in the RevMan software (<a href="./references#CD012622-bbs2-0095" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). For each outcome of interest, summary estimates of treatment effect (with 95% confidence intervals (CIs)) for each comparison were calculated. Where possible, risk ratios (RRs) with 95% CIs for dichotomous data and difference in means or standardised difference in means (SMD) with 95% CIs for continuous data were calculated. The results of individual studies were discussed and presented in table and graphical format, where data aggregation was not possible. </p> </section> <section id="CD012622-sec-0053"> <h4 class="title">Unit of analysis issues</h4> <p>The appropriate unit of analysis involved the type, intensity, and setting of non‐pharmacological interventions. A qualitative analysis using the GRADE approach for existing evidence was attempted in any event (<a href="./references#CD012622-bbs2-0065" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Higgins 2011</a>). Trials with multiple observations for the same outcome were assessed according to randomisation and types of interventions, and separate analyses based on different periods were performed. Studies with parallel groups were included, but only data from the first phase of cross‐over trials were included, due to the potential carry‐over effects in the second phase. </p> </section> <section id="CD012622-sec-0054"> <h4 class="title">Dealing with missing data</h4> <p>Insufficient data that were not available were reported but not included in the final analysis. We assumed the data were missing at random and only available data were analysed. </p> </section> <section id="CD012622-sec-0055"> <h4 class="title">Assessment of heterogeneity</h4> <p>We conducted statistically analysis, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012622-bbs2-0065" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Higgins 2011</a>). </p> </section> <section id="CD012622-sec-0056"> <h4 class="title">Assessment of reporting biases</h4> <p>Publication bias was minimised by performing comprehensive searches of multiple databases (<a href="./references#CD012622-bbs2-0050" title="EggerM , SmithGD . Bias in location and selection of studies. BMJ1998;16(7):61‐6. ">Egger 1998</a>). Where data were not reported in full for certain outcomes, we contacted the trial authors for the full data set or the reason for not publishing the data. Where sufficient studies (at least 10) were identified, we assessed potential biases of reporting using funnel plots and visual inspection for asymmetry according to the approach outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012622-bbs2-0065" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Higgins 2011</a>). </p> </section> <section id="CD012622-sec-0057"> <h4 class="title">Data synthesis</h4> <p>A meta‐analysis was not possible due to methodological, clinical and statistically heterogeneity of included studies. We would have pooled results from clinically similar studies for the meta‐analysis, if sufficient studies were available. </p> </section> <section id="CD012622-sec-0058"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Treatment effects in subgroups of trials were analysed and compared. With data that were available, we performed subgroup analysis for the following: </p> <p> <ul id="CD012622-list-0011"> <li> <p>sex (male/female);</p> </li> <li> <p>type of MS (relapsing remitting, progressive);</p> </li> <li> <p>Expanded Disability Status Scale (EDSS) (&lt; 6, &gt; 6);</p> </li> <li> <p>duration of follow‐up of the participants (three months; &gt; three months);</p> </li> <li> <p>type of non‐pharmacological intervention (unidisciplinary and/or multidisciplinary rehabilitation); and </p> </li> <li> <p>settings (i.e. inpatient, ambulatory care, community).</p> </li> </ul> </p> </section> <section id="CD012622-sec-0059"> <h4 class="title">Sensitivity analysis</h4> <p>We were unable to perform sensitivity analysis because the findings from included studies evidence were too small to allow reliable analysis. Further, we were not able to pool results from chronic pain of different central origins in the primary analyses, due to lack of data. </p> <p><b>'Summary of findings’ table</b> </p> <p>We presented the main results of the review in ’Summary of findings’ (SoF) tables, according to recommendations described in Chapter 11 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (version 5.1.0). We included an overall grading of the evidence for the following patient‐important outcomes: </p> <p> <ul id="CD012622-list-0012"> <li> <p>reduction in pain intensity;</p> </li> <li> <p>reduction in disability;</p> </li> <li> <p>improvement in quality of life;</p> </li> <li> <p>reduction in fatigue;</p> </li> <li> <p>reduction in depression and anxiety;</p> </li> <li> <p>reduction in pain interference, depression, fatigue;</p> </li> <li> <p>improvement in pain, self efficacy, patient activation, health‐related quality of life, social role satisfaction, resilience,positive and negative affect. </p> </li> </ul> </p> <p>We graded the quality of evidence for each outcome considering study limitations, indirectness, inconsistency, imprecision of effect estimates, and risk of reporting bias. According to the software GRADEpro 2008, we assigned four levels of quality of evidence: high, moderate, low, and very low. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012622-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012622-sec-0060"></div> <section id="CD012622-sec-0061"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD012622-sec-0101" title="">Characteristics of included studies</a> and <a href="./references#CD012622-sec-0102" title="">Characteristics of excluded studies</a> </p> <section id="CD012622-sec-0062"> <h4 class="title">Results of the search</h4> <p>Electronic and manual searches identified 558 references (MEDLINE =361; Embase = 138; CINAHL = 21; Central = 9; CRD database = 4; Handsearch = 7; WHO portal =4; Cinicaltrials.gov = 14). Of these 30 passed the first screening review and were selected for closer review. In total 10 articles fulfilled the inclusion criteria and were included. See <a href="#CD012622-fig-0001">Figure 1</a> for Study flow chart. </p> <div class="figure" id="CD012622-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012622-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012622-sec-0063"> <h4 class="title">Included studies</h4> <p>Overall, 10 randomised controlled trials (RCTs) (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>; <a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a><i>(</i>extension of <a href="./references#CD012622-bbs2-0118" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Use of self‐applied TENS for low back pain in people with multiple sclerosis. International Journal of Therapy and Rehabilitation2004 Jun;11(6):275‐80. ">Warke 2004</a>)) involving 565 participants fulfilled the inclusion criteria for this review. Two studies were conducted in Northern Ireland (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>); three studies in the USA (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>); two studies were from France (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>); and one study each from Spain (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>), Italy (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>) and Iran (<a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>).The included studies evaluated various non‐pharmacological interventions, which included: </p> <p> <ul id="CD012622-list-0013"> <li> <p>one study (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>) evaluated the effects of TENS, which used alternating currents by cutaneous electrodes positioned near the painful area; </p> </li> <li> <p>two studies (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>) investigated the effects of tDCS, which used a low current directly delivered to the brain for neuromodulation; </p> </li> <li> <p>two studies (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>) investigated the effects of reflexology, which involves the massaging of the feet which corresponds to different parts of the body; </p> </li> <li> <p>one study (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>) evaluated hydrotherapy; </p> </li> <li> <p>three studies (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>) evaluated psychotherapy, which used a telephone‐based self‐management educational program, self‐hypnosis and neurofeedback; </p> </li> <li> <p>one study (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>) evaluated tRNS, which used a form of neuromodulation through rapidly changing current frequencies. </p> </li> </ul> </p> </section> <section id="CD012622-sec-0064"> <h4 class="title">Excluded studies</h4> <p>Detailed descriptions of excluded studies with reason for exclusion is provided in <a href="./references#CD012622-sec-0102" title="">Characteristics of excluded studies</a>. Overall, 20 studies were excluded (<a href="./references#CD012622-bbs2-0011" title="AnninosP , AdamopoulosA , KotiniA , TsagasN . MEG evaluation of pico‐Tesla external TMS on multiple sclerosis patients. Multiple Sclerosis and Related Disorders2016;8:45‐53. ">Anninos 2016</a>; <a href="./references#CD012622-bbs2-0012" title="BackusD , ManellaC , BenderA , RugerL , Long , M . Massage therapy may help manage fatigue, pain and spasticity in people with multiple sclerosis​. Clinical Rehabilitation2013;27(12):1126‐36. ">Backus 2016</a>; <a href="./references#CD012622-bbs2-0013" title="BarlowJ , TurnerA , EdwardsR , GilchristM . A randomised controlled trial of lay‐led self‐management for people with multiple sclerosis. Patient Education and Counseling2009;77(1):81‐9. ">Barlow 2009</a>; <a href="./references#CD012622-bbs2-0014" title="CatenaL , BacciL , LombranoD , MoriciC , MorgantiniA . The effects of Pilates‐fisios on pain, motor fatigue, and quality of life in patients with multiple sclerosis: a randomized controlled clinical trial. Multiple Sclerosis2014;20(7):982. ">Catena 2014</a>; <a href="./references#CD012622-bbs2-0015" title="DoulatabadSN , NooreyanK , DoulatabadAN , NoubandeganZM . The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis. African Journal of Traditional, Complementary, and Alternative Medicines2012;10(1):49‐52. ">Doulatabad 2012</a>; <a href="./references#CD012622-bbs2-0016" title="HasanpourDA . Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial​. Journal of Sports Medicine and Physical Fitness2015;56(11):1417‐22. ">Hasanpour‐Dehkordi 2015</a>; <a href="./references#CD012622-bbs2-0017" title="Hasanpour‐DehkordiA , JivadN , SolatiK . Effects of yoga on physiological indices,anxiety and social functioning in multiple sclerosis patients: a randomized trial​. Journal of Clinical and Diagnostic Research2016;10(6):VC01‐05. ">Hasanpour‐Dehkordi 2016</a>; <a href="./references#CD012622-bbs2-0018" title="JensenMP , BarberJ , HanleyMA , RaichleKA , OsborneTL , MoltonIR , et al. The effects of self‐hypnosis training on pain in persons with multiple sclerosis. Focus on Alternative &amp; Complementary Therapies2007;12(s1):28‐9. ">Jensen 2007</a>; <a href="./references#CD012622-bbs2-0019" title="JensenMP , EhdeDM , GertzKJ , StoelbBL , DillworthTM , HirshAT , et al. Effects of self‐hypnosis training and cognitive restructuring on daily pain intensity and catastrophizing in individuals with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2011;59(1):45‐63. ">Jensen 2011</a>; <a href="./references#CD012622-bbs2-0020" title="MarinelliL , MoriL , SolaroC , UccelliA , PelosinE , CurraA , et al. Effect of radial shock wave therapy on pain and muscle hypertonia: a double‐blind study in patients with multiple sclerosis. Multiple Sclerosis Journal2015;21(5):622‐9. ">Marinelli 2015</a>; <a href="./references#CD012622-bbs2-0021" title="MathiowetzVG , FinlaysonML , MatuskaKM , ChenHY , LuoP . Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Multiple Sclerosis2005;11(5):592‐601. ">Mathiowetz 2005</a>; <a href="./references#CD012622-bbs2-0022" title="McGuireKB , Stojanovic‐RadicJ , StroberL , ChiaravallotiND , DeLucaJ . Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes. International Journal of MS Care2015;17(1):1‐8. ">McGuire 2015</a>; <a href="./references#CD012622-bbs2-0023" title="NegahbanH , RezaieS , GoharpeyS . Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study. Clinical Rehabilitation2013;27(12):1126‐36. ">Negahban 2013</a>; <a href="./references#CD012622-bbs2-0024" title="OkenBS , KishiyamaS , ZajdelD , BourdetteD , CarlsenJ , HaasM , et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology2004;62(11):2058‐64. ">Oken 2004</a>; <a href="./references#CD012622-bbs2-0025" title="PiluttiL , DlugonskiD , SandroffB , KlarenR , MotlR . Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Multiple Sclerosis2014;20(5):594‐601. ">Pilutti 2013</a>; <a href="./references#CD012622-bbs2-0026" title="PozzilliC , BrunettiM , AmicosanteAM , GasperiniC , RistoriG , PalmisanoL , et al. Home based management in multiple sclerosis: results of a randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2002;73(3):250‐5. ">Pozzilli 2002</a>; <a href="./references#CD012622-bbs2-0027" title="SeadaYI , NofelR , SayedHM . Comparison between trans‐cranial electromagnetic stimulation and low‐level laser on modulation of trigeminalneuralgia. Journal of Physical Therapy Science2013;25(8):911‐4. ">Seada 2013</a>; <a href="./references#CD012622-bbs2-0028" title="SmedalT , MyhrK‐M , AarsethJH , GjelsvikB , BeiskeAG , GladSB , StrandLI . The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis​. Acta Neurologica Scandinavica2011;124(1):45‐52. ">Smedal 2011</a>; <a href="./references#CD012622-bbs2-0029" title="StorrLK , SorensenPS , SorensenM . The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients. Multiple Sclerosis2006;12(2):235‐42. ">Storr 2006</a>; <a href="./references#CD012622-bbs2-0030" title="Van derLindenML , BulleyC , GeneenLJ , HooperJE , CowanP , MercerTH . Pilates for people with multiple sclerosis who use a wheelchair: feasibility, efficacy and participant experiences. Disability and Rehabilitation2013;36(11):1‐8. ">Van der Linden 2013</a>). Reasons for exclusion included: 13 studies did not define chronic pain as a criteria (<a href="./references#CD012622-bbs2-0015" title="DoulatabadSN , NooreyanK , DoulatabadAN , NoubandeganZM . The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis. African Journal of Traditional, Complementary, and Alternative Medicines2012;10(1):49‐52. ">Doulatabad 2012</a>; <a href="./references#CD012622-bbs2-0016" title="HasanpourDA . Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial​. Journal of Sports Medicine and Physical Fitness2015;56(11):1417‐22. ">Hasanpour‐Dehkordi 2015</a>; <a href="./references#CD012622-bbs2-0017" title="Hasanpour‐DehkordiA , JivadN , SolatiK . Effects of yoga on physiological indices,anxiety and social functioning in multiple sclerosis patients: a randomized trial​. Journal of Clinical and Diagnostic Research2016;10(6):VC01‐05. ">Hasanpour‐Dehkordi 2016</a>; <a href="./references#CD012622-bbs2-0020" title="MarinelliL , MoriL , SolaroC , UccelliA , PelosinE , CurraA , et al. Effect of radial shock wave therapy on pain and muscle hypertonia: a double‐blind study in patients with multiple sclerosis. Multiple Sclerosis Journal2015;21(5):622‐9. ">Marinelli 2015</a>; <a href="./references#CD012622-bbs2-0021" title="MathiowetzVG , FinlaysonML , MatuskaKM , ChenHY , LuoP . Randomized controlled trial of an energy conservation course for persons with multiple sclerosis. Multiple Sclerosis2005;11(5):592‐601. ">Mathiowetz 2005</a>; <a href="./references#CD012622-bbs2-0022" title="McGuireKB , Stojanovic‐RadicJ , StroberL , ChiaravallotiND , DeLucaJ . Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: description and outcomes. International Journal of MS Care2015;17(1):1‐8. ">McGuire 2015</a>; <a href="./references#CD012622-bbs2-0023" title="NegahbanH , RezaieS , GoharpeyS . Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study. Clinical Rehabilitation2013;27(12):1126‐36. ">Negahban 2013</a>; <a href="./references#CD012622-bbs2-0024" title="OkenBS , KishiyamaS , ZajdelD , BourdetteD , CarlsenJ , HaasM , et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology2004;62(11):2058‐64. ">Oken 2004</a>; <a href="./references#CD012622-bbs2-0025" title="PiluttiL , DlugonskiD , SandroffB , KlarenR , MotlR . Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Multiple Sclerosis2014;20(5):594‐601. ">Pilutti 2013</a>; <a href="./references#CD012622-bbs2-0026" title="PozzilliC , BrunettiM , AmicosanteAM , GasperiniC , RistoriG , PalmisanoL , et al. Home based management in multiple sclerosis: results of a randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2002;73(3):250‐5. ">Pozzilli 2002</a>; <a href="./references#CD012622-bbs2-0028" title="SmedalT , MyhrK‐M , AarsethJH , GjelsvikB , BeiskeAG , GladSB , StrandLI . The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis​. Acta Neurologica Scandinavica2011;124(1):45‐52. ">Smedal 2011</a>; <a href="./references#CD012622-bbs2-0029" title="StorrLK , SorensenPS , SorensenM . The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients. Multiple Sclerosis2006;12(2):235‐42. ">Storr 2006</a>; <a href="./references#CD012622-bbs2-0030" title="Van derLindenML , BulleyC , GeneenLJ , HooperJE , CowanP , MercerTH . Pilates for people with multiple sclerosis who use a wheelchair: feasibility, efficacy and participant experiences. Disability and Rehabilitation2013;36(11):1‐8. ">Van der Linden 2013</a>), two were abstracts only (<a href="./references#CD012622-bbs2-0014" title="CatenaL , BacciL , LombranoD , MoriciC , MorgantiniA . The effects of Pilates‐fisios on pain, motor fatigue, and quality of life in patients with multiple sclerosis: a randomized controlled clinical trial. Multiple Sclerosis2014;20(7):982. ">Catena 2014</a>; <a href="./references#CD012622-bbs2-0018" title="JensenMP , BarberJ , HanleyMA , RaichleKA , OsborneTL , MoltonIR , et al. The effects of self‐hypnosis training on pain in persons with multiple sclerosis. Focus on Alternative &amp; Complementary Therapies2007;12(s1):28‐9. ">Jensen 2007</a>), three were not clinical controlled trials (<a href="./references#CD012622-bbs2-0012" title="BackusD , ManellaC , BenderA , RugerL , Long , M . Massage therapy may help manage fatigue, pain and spasticity in people with multiple sclerosis​. Clinical Rehabilitation2013;27(12):1126‐36. ">Backus 2016</a>; <a href="./references#CD012622-bbs2-0019" title="JensenMP , EhdeDM , GertzKJ , StoelbBL , DillworthTM , HirshAT , et al. Effects of self‐hypnosis training and cognitive restructuring on daily pain intensity and catastrophizing in individuals with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2011;59(1):45‐63. ">Jensen 2011</a>; <a href="./references#CD012622-bbs2-0027" title="SeadaYI , NofelR , SayedHM . Comparison between trans‐cranial electromagnetic stimulation and low‐level laser on modulation of trigeminalneuralgia. Journal of Physical Therapy Science2013;25(8):911‐4. ">Seada 2013</a>), and two trials did not have pain as an outcome (<a href="./references#CD012622-bbs2-0011" title="AnninosP , AdamopoulosA , KotiniA , TsagasN . MEG evaluation of pico‐Tesla external TMS on multiple sclerosis patients. Multiple Sclerosis and Related Disorders2016;8:45‐53. ">Anninos 2016</a>; <a href="./references#CD012622-bbs2-0013" title="BarlowJ , TurnerA , EdwardsR , GilchristM . A randomised controlled trial of lay‐led self‐management for people with multiple sclerosis. Patient Education and Counseling2009;77(1):81‐9. ">Barlow 2009</a>). </p> </section> </section> <section id="CD012622-sec-0065"> <h3 class="title">Risk of bias in included studies</h3> <p>For a summary, please see Risk of bias’ tables in the <a href="./references#CD012622-sec-0101" title="">Characteristics of included studies</a> and <a href="#CD012622-fig-0002">Figure 2</a> and <a href="#CD012622-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD012622-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012622-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012622-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012622-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD012622-sec-0066"> <h4 class="title">Allocation</h4> <p><b>Random sequence generation</b> </p> <p>Nine studies were considered to have a low risk of bias for this domain (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>; <a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a> was considered to have an unclear risk of bias for this domain as randomisation not discussed. </p> <p><b>Allocation concealment</b> </p> <p>One study (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>) was considered to have a low risk of bias for allocation concealment as the allocation sequence was concealed from the research assistants who enrolled participants via a limited access database program. The other nine studies were considered to have an unclear risk of bias for allocation concealment (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </section> <section id="CD012622-sec-0067"> <h4 class="title">Blinding</h4> <p><b>Blinding of participants and personnel (performance bias)</b> </p> <p>Blinding of participants for performance bias was assessed as high risk in two studies (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>;<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>), as the study could not guarantee the study was blinded and no blinding reported, respectively. Two studies had an unclear risk of bias (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>). The remaining six studies had a low risk of bias (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> <p><b>Blinding of participants and personnel (detection bias)</b> </p> <p>Two studies were assessed as unclear risk for blinding of outcome assessment as blinding was not described (<a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>) and two studies were assessed as high risk (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </section> <section id="CD012622-sec-0068"> <h4 class="title">Incomplete outcome data</h4> <p>All studies provided information on participant withdrawals and loss to follow‐up. Two studies ( <a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>) reported loss of participants to follow‐up and were assessed as high risk; the remaining studies were considered to be at low risk of bas. </p> </section> <section id="CD012622-sec-0069"> <h4 class="title">Selective reporting</h4> <p>All included studies assessed pre‐specified primary and secondary outcomes and were assessed as 'low' risk. </p> </section> <section id="CD012622-sec-0070"> <h4 class="title">Other potential sources of bias</h4> <p>Two studies (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>) were assessed as unclear risk as funding was received but it was unclear if it had an impact on results. </p> </section> </section> <section id="CD012622-sec-0071"> <h3 class="title" id="CD012622-sec-0071">Effects of interventions</h3> <p>See: <a href="./full#CD012622-tbl-0001"><b>Summary of findings for the main comparison</b> Transcutaneous Electrical Nerve Stimulation (TENS) compared to Sham for Chronic Back Pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0002"><b>Summary of findings 2</b> Ai Chi Exercises compared to Sham for Chronic Musculoskeletal pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0003"><b>Summary of findings 3</b> Transcranial Direct Current Stimulation (tDCS) compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0004"><b>Summary of findings 4</b> Transcranial Random Noise Stimulation (tRNS)compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0005"><b>Summary of findings 5</b> Telephone‐Delivered Education Group compared to Sham for Chronic pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0006"><b>Summary of findings 6</b> Hypnosis compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0007"><b>Summary of findings 7</b> Neurofeedback compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</a>; <a href="./full#CD012622-tbl-0008"><b>Summary of findings 8</b> Reflexology compared to Sham for Chronic Pain in Multiple Sclerosis (MS)</a> </p> <p>As aforementioned, the included studies used a wide range of non‐pharmacological interventions and used various assessments relating to pain measures. Key findings based on the interventions evaluated and summary of findings are described below and tabulated in 'Summary of Finding' tables. A meta‐analysis was not possible and narrative descriptions of the findings are presented instead. </p> <section id="CD012622-sec-0072"> <h4 class="title">Transcutaneous electrical nerve stimulation (TENS)</h4> <p>One study (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>) evaluated the effects of TENS on chronic low back pain in persons with multiple sclerosis (pwMS). (<a href="./full#CD012622-tbl-0001">summary of findings Table for the main comparison</a>) </p> <p>In this study, 90 participants were randomised into three groups (N = 30 in each): low‐frequency TENS, high‐frequency TENS and placebo (sham). There was a decrease in low back pain scores overtime in all three groups in visual analogue scores (VAS), however, none reached statistical significance. Similarly, no statistically significant changes in the McGIll Pain Questionnaire (MPQ) was found in all three groups. All three groups showed improvement in patient‐reported disability scores ( Roland Morris Disability Questionnaire (RMDQ)), however, it was not statistically significant. </p> </section> <section id="CD012622-sec-0073"> <h4 class="title">Hydrotherapy</h4> <p>One RCT (N = 73 participants) (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>) evaluated the effectiveness of Ai Chi water‐based exercise program compared to placebo. The participants in the intervention group received Ai Chi water exercises twice a week for 20 weeks. The authors reported significant reduction in pain VAS score in the treatment group immediately after treatment (P = 0.028), which was maintained up to 30 weeks (P = 0.047). There were no statistical significance changes in the control group at any time point. Similarly, compared to the control group, the treatment group showed a significant pain reduction at week 20 in MPQ and was maintained up to week 24 (P &lt; 0.021). There were significant decreases in disability (RMDQ) scores in both groups at week 20. The treatment group also showed a significant decrease in spasm VAS score at week 20 compared to the control group (P = 0.039). Both groups showed a significant reduction in the Multiple sclerosis Impact scale 29 (MSIS‐29) psychological score at week 20. (<a href="./full#CD012622-tbl-0002">summary of findings Table 2</a>) </p> </section> <section id="CD012622-sec-0074"> <h4 class="title">Transcranial direct stimulation (tDCS)</h4> <p>Two studies (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>) evaluated the effectiveness of tDCS in pwMS. (<a href="./full#CD012622-tbl-0003">summary of findings Table 3</a>) </p> <p>One RCT (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>) (N = 16) randomised participants to either anodal tDCS (N = 8) or sham (N = 8) groups. The findings showed a statistically significant difference between before and after treatment for mean pain VAS scores in the treatment group (P = 0.024). There were no statistically significant changes in the sham group. Active stimulation resulted in significant improvement in pain ( Brief Pain Inventory (BPI) global score) (P = 0.02), but no significant effects on severity, or in the sham group. There were no significant differences observed through stimulation for both groups for functional and psychological outcomes for MFIS and HADS. </p> <p>In another study (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>), participants (N = 19) were randomised to anodal tDCS (N = 10) or sham (N = 9) groups. There were statistically and clinical significant changes for pain VAS and MPQ scores in the anodal tDCS group compared to the control sham group (P &lt; 0.05). The authors also reported statistically significant changes for the treatment effect over time in quality of life (QoL) for the Multiple Sclerosis Quality of Life‐54 (MSQOL54) and the Short Form Mcgill Pain Questionnaire (SFMPQ). There were no statistically significant changes for other psychological outcomes ( Beck Depression Inventory (BDI) and VAS for anxiety) in both groups. </p> </section> <section id="CD012622-sec-0075"> <h4 class="title">Transcranial random noise stimulation (tRNS)</h4> <p>One RCT (N = 16 participants) (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>) examined the effect of tRNS in comparison with the sham. The authors found no statistically significant changes for mean pain VAS score before and after treatment for both tRNS and sham groups. There was a significant change in BPI in the treatment group but not in the sham group. Further, there were no statistically significant changes for any psychological and functional outcomes ( Hospital Anxiety and Depression Scale HADS), Modified Fatigue Impact Scale (MFIS) scores) in both groups. (<a href="./full#CD012622-tbl-0004">summary of findings Table 4</a>) </p> </section> <section id="CD012622-sec-0076"> <h4 class="title">Psychotherapy</h4> <p>Three RCTs (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>) evaluated different forms of psychotherapy. (<a href="./full#CD012622-tbl-0005">summary of findings Table 5</a>, <a href="./full#CD012622-tbl-0006">summary of findings Table 6</a> and <a href="./full#CD012622-tbl-0007">summary of findings Table 7</a>) </p> <p>One RCT (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>) (N = 163 participants) compared a telephone‐delivered self‐management program with the control group receiving telephone‐delivered educational program. The authors reported that &gt; 50% reduction in one or more symptoms (fatigue, pain interference and depression severity) was achieved in 58% of the intervention group and 46% of the control group. However, this was not statistically significant. There were no clinical significant changes in pain intensity after treatment and at follow‐up in both intervention and control group. The authors reported statistically significant improvements in all secondary outcomes (fatigue, self‐efficacy, pain interference quality of life) for both groups, which was maintained up to six‐ and 12‐month follow‐up. </p> <p>Another RCT (<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>) evaluating the effectiveness of self‐hypnosis on pain in pwMS, randomised (N = 22) participants to self‐hypnosis (N = 15) and progressive muscle relaxation (N = 7) groups. The authors found statistically and clinically significant changes pre‐ and post‐ treatment in the hypnosis group in reduction in daily pain intensity but not in the control group (P &lt; 0.001). There was also statistically significant change pre‐ to post‐treatment in the hypnosis group, but not in the progressive relaxation group for pain interference (P &lt; 0.001). </p> <p>Another RCT (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>) randomised (N = 20) participants to the EEG biofeedback (N = 10) group or relaxation control group (N = 10). Both groups improved in pain scores soon after treatment and at one‐month follow‐up, however this was not statistically significant. There was a moderate to large improvement in the neurofeedback group after treatment (effect size, ES = 0.70) and 1 month after follow‐up (ES = 1.04), but effect size of improvement was much lower in the control group. There were improvements for other pain scores (BPI, worst pain intensity) and fatigue severity in the intervention group with moderate to large effect size. </p> </section> <section id="CD012622-sec-0077"> <h4 class="title">Reflexology</h4> <p>Reflexology was evaluated in two studies (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>). (<a href="./full#CD012622-tbl-0008">summary of findings Table 8</a>) </p> <p>One RCT (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>) (N = 71 participants) compared reflexology with a control group with sham intervention. The authors found clinical and statistically significant reduction in pain VAS scores at 10 weeks compared to baseline in both groups (P = 0.0001), which was maintained up to 22 weeks. Both groups demonstrated significant reduction in MPQ pain rating index at week 10. For MPQ pain index there were no changes in the sham group, but a statistically significant change at week 10 for the reflexology group (P &lt; 0.012). Both groups showed a significant reduction in disability score measured by RMDQ at 10 weeks . Further, both groups had a similar statistically significant decrease in VAS spasm score by the end of the treatment period. Both groups showed significant reductions in psychology and physical subscales of MSIS at week 10. There was a significant reduction by week 10 in both groups in fatigue (MFIS, Fatigue Severity Scale (FSS) scores), with no significant differences between groups. There was a significant reduction in psychological outcomes (BDI scores) by week 10 in both groups. Functional improvements (measured by the Barthel Index (BI)) in both groups remained stable throughout treatment by week 10 . </p> <p>Another RCT (<a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>) (N = 75 participants) randomised participants to either reflexology, relaxation or control groups. There were statistically and clinical significant differences in pain scores in the reflexology group (P &lt; 0.001) and relaxation group (P = 0.01) pre‐ and post‐treatment, while no significant changes were found in the control group (P = 0.34). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012622-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012622-sec-0078"></div> <section id="CD012622-sec-0079"> <h3 class="title" id="CD012622-sec-0079">Summary of main results</h3> <p>Overall, 10 RCTs with 565 participants fulfilled the inclusion criteria of this review, which evaluated various non‐pharmacological interventions for the management of chronic pain in persons with multiple sclerosis (pwMS), which included: physical therapy (Ai Chi water exercise), psychotherapy (telephone self‐management, cognitive restructuring, neurofeedback and hypnosis), neuromodulatory techniques (transcranial direct stimulation (tDCS), transcranial random noise stimulation (tRNS)), reflexology and transcutaneous electrical nerve stimulation (TENS). The included trials were heterogeneous in terms of: type and intensity of interventions evaluated and outcome measures used. The study quality varied and formulating pooled evidence was limited due to high risk of bias, underpowered studies (small sample size) and lack of data on changes of pain outcomes in majority of the studies. Therefore, quantitative synthesis was not possible and a qualitative synthesis of ’best evidence ' was summarised. </p> <p>The findings suggest that there is 'very low level' evidence for the following interventions.</p> <p> <ul id="CD012622-list-0014"> <li> <p>TENS in reducing lower back pain.</p> </li> <li> <p>Ai Chi water exercises in improving pain intensity which was maintained up to 30 weeks. There were also improvements in spasm, quality of life(QoL) and fatigue. </p> </li> <li> <p>tDCS in reduction in pain intensity and up to three weeks after treatment and improvement in QoL, but not in fatigue and anxiety and depression. </p> </li> <li> <p>tRNS in improving pain scores, depression or anxiety or fatigue.</p> </li> <li> <p>Telephone‐delivered self‐management program for the reduction of pain intensity, catastrophisation, self‐efficacy, fatigue and QoL in chronic pain. </p> </li> <li> <p>EEG biofeedback for reduction in pain intensity and fatigue and pain interference.</p> </li> <li> <p>Reflexology in reducing pain intensity, disability, fatigue, psychological and physical impact and depression up to 22 weeks. </p> </li> </ul> </p> </section> <section id="CD012622-sec-0080"> <h3 class="title" id="CD012622-sec-0080">Overall completeness and applicability of evidence</h3> <p>Despite a comprehensive search of the literature, only 10 trials evaluating a wide variety of non‐pharmacological treatments fulfilled the inclusion criteria. Due to the quality of the published studies, many aspects of non‐pharmacological interventions for multiple sclerosis (MS) pain remain unproven. Further, there were only few studies (which were heterogeneous) that evaluated a given type of intervention, which did not permit pooling data for quantitative analyses. There are other non‐pharmacological interventions (e.g. yoga, massage therapy and radial shock wave therapy) which have been used for pain relief in pwMS, however, studies evaluating these interventions did not fulfil the inclusion criteria for this review. Cost‐effectiveness of the intervention and reporting of safety or adverse events for participants were not evaluated in any of the included trials. Ovwerall, the review identified many issues relating to the studies evaluating non‐pharmacological interventions in chronic pain in MS; which could affect the overall completeness and applicability of evidence. The gaps in the evidence base for non‐pharmacological management of chronic pain in pwMS include the following. </p> <p> <ul id="CD012622-list-0015"> <li> <p>Limited and/or lack of high‐quality evidence for the effectiveness of non‐pharmacological interventions. </p> </li> <li> <p>Complexity and different mechanisms related to chronic pain in MS.</p> </li> <li> <p>Broad range of non‐pharmacological interventions used in different context and with scope. </p> </li> <li> <p>Difficulty of blinding and incorporation of a control or placebo (sham).</p> </li> <li> <p>Lack of use of Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) recommendations for measures of significance and standardised measurement outcomes. </p> </li> <li> <p>Difficultty with knowing the effective dose or duration for many non‐pharmacological interventions due to lack of definitive mechanisms. </p> </li> </ul> </p> <p>Non‐pharmacological interventions are therapist‐ and operator‐dependent and may be prone to multiple combined mechanisms or 'bundled effects' (<a href="./references#CD012622-bbs2-0038" title="BennettMI , ClossSJ . Methodological issues in non pharmacological trials for chronic pain. Anaesthesia, Pain and Intensive Care2011;15:126–32. ">Bennett 2011</a>). Suggestions for future improvements in quality of evidence include robust studies emphasising on the mechanisms of pain in MS. </p> </section> <section id="CD012622-sec-0081"> <h3 class="title" id="CD012622-sec-0081">Quality of the evidence</h3> <p>All 10 included studies were rated as ' very low' quality for methodological evidence due to risk of bias and flaws in their methodological design (<a href="#CD012622-fig-0002">Figure 2</a>; <a href="#CD012622-fig-0003">Figure 3</a>). </p> <p> <ul id="CD012622-list-0016"> <li> <p>Lack of reporting of blinding and blinding processes (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>; <a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </li> <li> <p>Underpowered from low sample size and lack of study power calculation.</p> </li> <li> <p>Lack of reporting in IMMPACT suggestion of &gt; 30% or 50% change in pain scores for clinical significance. </p> </li> <li> <p>Limited reporting of complete data.</p> </li> <li> <p>Lack of allocation concealment (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>; <a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>; <a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>; <a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>; <a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>; <a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>; <a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>; <a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </li> <li> <p>Unclear in the reporting of study authors' conflicts of interest, funding sources (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>; <a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </li> <li> <p>Diffilculty controlling for therapist‐dependent bias, patient motivation and activity/interventions outside of treatment. </p> </li> </ul> </p> <p>In summary, these limitations affected the quality of the evidence and highlights the importance of good methodological practices in research. This is specially important given the difficulty in recruitment of targeted study cohorts (with adequate sample sizes) and difficulties associated with controlling for patients’ personal and other confounding factors such as, patient motivation and self‐efficacy, comorbidity and activity level outside of therapy programmes), which influence compliance and delivery of therapy, thus impacting on outcomes. </p> </section> <section id="CD012622-sec-0082"> <h3 class="title" id="CD012622-sec-0082">Potential biases in the review process</h3> <p>The review authors followed a number of steps to ensure the reduction of bias in the review process. First, the review authors independently reviewed and assessed all articles. Second, the review authors adhered strictly to the inclusion and exclusion criteria for the studies and extraction and interpretation of the data, and followed the GRADE handbook. However, a number of limitations in the methodological quality of the review itself, and the completeness of the retrieved literature, cannot be ruled out. Despite the extended range of terms that were used to capture the widest possible selection of the relevant literature, we were not able to rule out some degree of selection bias from the literature search (<a href="./references#CD012622-bbs2-0113" title="vanTulderMW , FurlanA , BombardierC , BouterL . Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine2003;28(12):1290‐9. ">van Tulder 2003</a>). Possibility of publication bias cannot be omitted as we were not able to include negative trials or other trials which are yet to be published in academic literature (<a href="./references#CD012622-bbs2-0050" title="EggerM , SmithGD . Bias in location and selection of studies. BMJ1998;16(7):61‐6. ">Egger 1998</a>). Further, reference bias (<a href="./references#CD012622-bbs2-0059" title="GoetzschePC . Reference bias in reports of drug trials. British Medical Journal1987;295:654‐6. ">Goetzsche 1987</a>) is a further possibility, as we searched only reference lists within the relevant papers for additional articles. We welcome contact from any readers who are aware of important high‐quality studies which are not included in this review. </p> </section> <section id="CD012622-sec-0083"> <h3 class="title" id="CD012622-sec-0083">Agreements and disagreements with other studies or reviews</h3> <p>There are limited systematic reviews in the area of non‐pharmacological management of chronic pain in MS. This review highlights existing evidence and gaps in the literature. There are some similarities which are consistent between this review and another published non‐Cochrane systematic review (<a href="./references#CD012622-bbs2-0069" title="JawaharR , OhU , YangS , LapaneKL . Alternative approach: a systematic review of non‐pharmacological non‐spastic and non‐trigeminal pain management in multiple sclerosis. European Journal of Physical and Rehabilitation Medicine2014;50(5):567‐77. ">Jawahar 2014</a>). However, there are methodological differences of this review and the review by Jawar et al (<a href="./references#CD012622-bbs2-0069" title="JawaharR , OhU , YangS , LapaneKL . Alternative approach: a systematic review of non‐pharmacological non‐spastic and non‐trigeminal pain management in multiple sclerosis. European Journal of Physical and Rehabilitation Medicine2014;50(5):567‐77. ">Jawahar 2014</a>). specifically inclusion of only high‐quality studies (randomised controlled trials (RCTs) and clinical controlled trials (CCTs)) and use of standardised tools ‐ the<i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD012622-bbs2-0065" title="HigginsJPT , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions. Chichester (UK): John Wiley &amp; Sons, 2008. ">Higgins 2011</a>) and the 'GRADE' for the methodology and interpretation of findings. We think this review addressed the methodological issues in systematically reviewing the evidence for the management of chronic pain in pwMS (<a href="./references#CD012622-bbs2-0038" title="BennettMI , ClossSJ . Methodological issues in non pharmacological trials for chronic pain. Anaesthesia, Pain and Intensive Care2011;15:126–32. ">Bennett 2011</a>). This is reflected in the findings of various issues within the included studies in this review, included blinding, small sample sizes, determination of the right dose/duration of treatment and focus on other outcome measures other than pain intensity such as adverse effects and patient compliance and adherence to therapy. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012622-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/urn:x-wiley:14651858:media:CD012622:CD012622-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_t/tCD012622-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012622-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012622-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/urn:x-wiley:14651858:media:CD012622:CD012622-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_t/tCD012622-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012622-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012622-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/urn:x-wiley:14651858:media:CD012622:CD012622-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_t/tCD012622-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012622-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/media/CDSR/CD012622/image_n/nCD012622-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transcutaneous Electrical Nerve Stimulation (TENS) compared to Sham for Chronic Back Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcutaneous electrical nerve stimulation (TENS) compared to sham for chronic back pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic back pain in MS<br/> <b>Setting:</b> participants from Multiple Sclerosis Society in Northern Ireland<br/> <b>Intervention:</b> TENS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i> </p> <p>assessed with: VAS, MPQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Decrease in low back pain scores overtime for all groups, however, none reached clinical or statistical significance in VAS scores. No statistically significant changes in MPQ (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). VAS mean reduction for TENS low frequency at week 6 was ‐16.59 (weekly low back pain) and ‐19.76 (average low back pain). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i> </p> <p>assessed with: RMDQ, BI</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant changes in disability measured by RMDQ and BI between treatment and placebo groups and within‐groups (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Quality of Life</b> </i> </p> <p>assessed with: LMSQoLQ, SF‐36</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant difference in quality of life measured by LMSQoLQ or SF‐36 between treatment and placebo groups (<a href="./references#CD012622-bbs2-0010" title="WarkeK , Al‐SmadiJ , BaxterGD , WalshDM , Lowe‐StrongAS . Efficacy of transcutaneous electrical nerve stimulation (TENS) for chronic low‐back pain in a multiple sclerosis population: a randomized, placebo‐controlled clinical trial. Clinical Journal of Pain2006;22(9):812‐9. ">Warke 2006</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BI:</b> Barthel Index; <b>MPQ:</b> McGill Pain Questionnaire; <b>LMSQoLQ</b> : Leeds Multiple Sclerosis Quality of Life Questionnaire; <b>RMDQ:</b> Roland Morris Disability Questionnaire; <b>SF‐36</b> : Short Form 36; <b>VAS:</b> Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup>Downgraded two levels due to high risk for bias (unclear allocation concealment) </p> <p><sup>2</sup>Downgraded two levels due to high risk of bias for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Transcutaneous Electrical Nerve Stimulation (TENS) compared to Sham for Chronic Back Pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ai Chi Exercises compared to Sham for Chronic Musculoskeletal pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Ai Chi exercises compared to sham for chronic musculoskeletal pain in multiple sclerosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic musculoskeletal pain in people with MS<br/> <b>Setting:</b> participants were recruited from MS Association of Almeria in Spain<br/> <b>Intervention:</b> Ai Chi exercises<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i> </p> <p>assessed with: VAS, MPQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant reduction in pain scores measured by VAS in the treatment group immediately after treatment and no significant change from baseline in the control group. Pain VAS at week 20 was 50% (experimental) and 23% (control). </p> <p>Significant pain reduction for MPQ in the treatment group and no significant change from baseline in the control group (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i> </p> <p>assessed with: RMDQ</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant reduction in disability measured by RMDQ in intervention and control group at week 20 (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Quality of Life</b> </i> </p> <p>assessed with: MSIS‐29</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both groups showed a significant reduction in the psychological sub scale of the MFIS at week 20. Treatment group showed significant score reduction but the control group showed no significant difference with baseline score in the physical sub scale at week 20 (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Fatigue</b> </i><br/> assessed with:MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Treatment group showed a significant score reduction compared with baseline at week 20, but no significant difference in control group. Treatment group showed a significant reduction in cognitive scale compared with the control group (<a href="./references#CD012622-bbs2-0002" title="Castro‐SanchezAM , Mataran‐PenarrochaIGA , Lara‐PalomoI , Saavedra‐HernandezM , Arroyo‐MoralesM , Moreno‐LorenzoC . Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evidence‐Based Complementary and Alternative Medicine2012;12:1‐8. ">Castro‐Sanchez 2012</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>MFIS:</b> Modified Fatigue Impact Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>MSIS‐29</b> : Multiple Sclerosis Impact Scale‐29; <b>RMDQ:</b> Roland Morris Disability Questionnaire, <b>SF‐36</b> : Short Form 36; <b>VAS</b>: Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels because the singular study was considered at serious risk of performance bias ( blinding of participants and personnel ) and unclear risk of allocation concealment </p> <p><sup>2</sup> Downgraded two levels due to imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Ai Chi Exercises compared to Sham for Chronic Musculoskeletal pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Transcranial Direct Current Stimulation (tDCS) compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcranial direct current stimulation (tDCS) compared to sham for chronic neuropathic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic neuropathic pain in MS<br/> <b>Setting</b> : community neurology clinic<br/> <b>Intervention:</b> tDCS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Pain Intensity</b> </i><br/> assessed with: VAS, BPI, MPQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean pain VAS showed significant decrease after active tDCS (mean baseline 51.2; after treatment 43.1) but no significant change after sham (mean baseline 52.1; after treatment 50.3). BPI global score for active tDCS resulted in significant improvement on the interference sub scale but no significant effects on the severity sub scale (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> <p>Significant main effect of time for decreased daily pain VAS (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LO</b>W <sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>There was no significant difference in fatigue measured by the MFIS between groups (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in depression and anxiety</b> </i><br/> assessed with: BDI, HADS, VAS for anxiety </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No significant differences in depression and anxiety were observed for both groups on HADS (<a href="./references#CD012622-bbs2-0001" title="AyacheSS , PalmU , ChalahMA , Al‐AniT , BrignolA , AbdellaouiM , et al. Prefrontal tDCS decreases pain in patients with multiple sclerosis. Frontiers in Neuroscience2016;10:147‐51. ">Ayache 2016</a>). </p> <p>No significant changes for BDI and VAS for anxiety with time as within subjects and group of treatment as between subjects. (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in QoL</b> </i><br/> assessed with: MSQOL54 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Significant effect of time and group x time interaction for improved quality of life measured by the MSQOL54 (<a href="./references#CD012622-bbs2-0007" title="MoriF , CodecaC , KusayanagiH , MonteleoneF , ButtariF , FioreS , et al. Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. Journal of Pain2010;11(5):436‐42. ">Mori 2010</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>19<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BDI:</b> Beck Depression Inventory; <b>HADS</b> : Hospital Anxiety and Depression Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>MSQOL54:</b> Multiple Sclerosis Quality of Life 54. <b>QoL</b> : Quality of life, <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level for risk for bias (the two studies at unclear risk of bias in allocation concealment) </p> <p><sup>2</sup> Downgraded two levels for high risk for imprecision (small sample sizes of both studies) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Transcranial Direct Current Stimulation (tDCS) compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Transcranial Random Noise Stimulation (tRNS)compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Transcranial Random Noise Stimulation (tRNS) compared to sham for chronic neuropathic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic neuropathic pain in MS<br/> <b>Setting:</b> hospital MS clinics<br/> <b>Intervention:</b> tRNS<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain</b> </i><br/> assessed with: VAS, BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistically significant changes for mean pain VAS treatment (mean VAS before 50.1; mean<br/> VAS after 47.2) and sham groups (mean VAS before: 52.1; mean VAS after:50.3). </p> <p>No statistical significance before and after stimulation sham and treatment for BPI (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in anxiety and depression</b> </i><br/> assessed with: HADS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistical significance before and after for treatment and sham for mean HADS (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>No statistical significance before and after sham and treatment for mean total score (<a href="./references#CD012622-bbs2-0009" title="PalmU , ChalahMA , PadbergF , Al‐AniT , AbdellaouiM , SorelM , et al. Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis. Restorative Neurology and Neuroscience2016;34(2):189‐99. ">Palm 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Beck Pain Inventory; <b>HADS</b> : Hospital Anxiety and Depression Scale; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels because the singular study was considered at high risk of bias (unclear risk of bias in randomisation sequence generation, allocation concealment and blinding of outcome assessors) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Transcranial Random Noise Stimulation (tRNS)compared to Sham for Chronic Neuropathic Pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Telephone‐Delivered Education Group compared to Sham for Chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Telephone‐delivered education compared to sham for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> participants' home across United States<br/> <b>Intervention:</b> telephone‐delivered education group<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference, depression,fatigu</b> </i>e<br/> assessed with: BPI, PHQ‐9, MFIS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>58% of telephone self‐management group and 46% of telephone education group had &gt; 50% reduction in 1 or more symptoms (fatigue, pain, depression), but not statistically significant (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>163<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in pain, self efficacy,patient activation, health‐related quality of life, social role satisfaction,resilience,positive and negative affect</b> </i><br/> assessed with: Average Pain Intensity, UWSES, Patient Activation Measure, Medical Outcomes Study 8 Item Short Form Heath Survey, Patient Reported Outcomes Measurement Information System Short‐Form,Connor‐Davidson Resilience Scale </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant improvements in all secondary outcomes for fatigue, pain interference, self efficacy and QoLcompared with telephone education group (<a href="./references#CD012622-bbs2-0003" title="EhdeDM , ElzeaJL , VerrallAM , GibbonsLE , SmithAE , AmtmannD . Efficacy of a telephone‐delivered self‐management intervention for persons with multiple sclerosis: a randomized controlled trial with a one‐year follow‐up. Archives of Physical Medicine and Rehabilitation2015;96(11):1945‐58. ">Ehde 2015</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>163<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>MPQ:</b> McGill Pain Questionnaire; <b>PHQ‐9</b> :Patient Health Questionnaire 9; <b>QoL</b> : quality of life; <b>UWSES</b>:University of Washington Self Efficacy Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk of bias (the singular study at high risk of bias in blinding of outcome assessor and attrition) </p> <p><sup>2</sup> Downgraded two levels due to high risk of bias for imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Telephone‐Delivered Education Group compared to Sham for Chronic pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Hypnosis compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Hypnosis compared to relaxation/control for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics<br/> <b>Intervention:</b> hypnosis<br/> <b>Comparison:</b> relaxation/control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain intensity</b> </i><br/> assessed with: Average Pain Intensity, Daily Pain Intensity (Numeric Rating Scale) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant changes pre and post treatment for hypnosis group but not in progressive relaxation group. Statistically significant decrease in daily/average pain scores for the self hypnosis group but not significant in the progressive muscle relaxation group (<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference</b> </i><br/> assessed with: BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Statistically significant change pre to post treatment in the hypnosis group but not in the progressive relaxation group (<a href="./references#CD012622-bbs2-0005" title="JensenMP , BarberJ , RomanoJM , MoltonIR , RaichleKA , OsborneTL , et al. A comparison of self‐hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain. International Journal of Clinical and Experimental Hypnosis2009;57(2):198‐221. ">Jensen 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk for bias (the singular study did not describe whether blinding had occurred for participants) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Hypnosis compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Neurofeedback compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Neurofeedback compared to relaxation/control for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics<br/> <b>Intervention:</b> neurofeedback<br/> <b>Comparison:</b> relaxation/control </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain Intensity</b> </i><br/> assessed with: Numerical Rating Scale (average) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both groups improved soon after intervention and at 1‐month follow‐up, but not statically significant. Average mean pain intensity for intervention (before 5.30; after:4.41; 1 month 3.98) and control (before 5.24; after 4.32; 1 month 4.31). Worst pain intensity score improvements in intervention (before 6.68; after 5.90; 1 month 5.18) and control (before 6.38; after 5.49; 1 month 5.35) (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in fatigue</b> </i><br/> assessed with: FSS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Improvements over time pre to post treatment in intervention (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain interference</b> </i><br/> assessed with: BPI </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>BPI score improvement in both groups (<a href="./references#CD012622-bbs2-0006" title="JensenMP , GianasA , GeorgeHR , SherlinLH , KraftGH , EhdeDM . Use of neurofeedback to enhance response to hypnotic analgesia individuals with multiple sclerosis. International Journal of Clinical and Experimental Hypnosis2016;64(1):1‐23. ">Jensen 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BPI:</b> Brief Pain Inventory;<b>FSS:</b> Fatigue Severity Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk for bias (unclear allocation concealment and no blinding of outcome assessors) </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (singular study of small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Neurofeedback compared to relaxation control for chronic pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012622-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Reflexology compared to Sham for Chronic Pain in Multiple Sclerosis (MS)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Reflexology compared to sham for chronic pain in MS</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Patient or population:</b> chronic pain in MS<br/> <b>Setting:</b> MS clinics, MS society<br/> <b>Intervention:</b> reflexology<br/> <b>Comparison:</b> sham </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Impact</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in pain</b> </i><br/> assessed with: VAS, MPQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Compared to baseline; significant decrease in median pain VAS in both reflexology (50% decrease at week 10) and sham (50% decrease at week 10) (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). Significant reduction in BPI scores in both groups, reflex group but no significant differences between groups. (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> <p>There were changes in mean pain VAS in both reflexology (pre‐test 5.72, post‐test 3.16, 2 months 4.64) and control (pre‐test 5.88, post‐test 5.60, 2 months 5.32) (<a href="./references#CD012622-bbs2-0008" title="NazariF , SoheiliM . A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis. Journal of Complementary and Integrative Medicine2016;13(1):65‐71. ">Nazari 2016</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in disability</b> </i><br/> assessed with: BI, RMDQ </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both the intervention and sham groups showed a significant decrease in RMDQ by the end of the treatment period.BI scores in both groups remained relatively stable throughout the duration of the trial in both groups (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Improvement in Quality of Life</b> </i><br/> assessed with: MSIS‐29 </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MSIS‐29 psychological sub scale improved in both intervention and sham by week 10.</p> <p>Physical sub scale significant decrease in both intervention and sham, however this reduction was greater in the treatment group by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1, 2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Fatigue</b> </i> <br/> assessed with: MFIS, FSS </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MFIS physical sub scale score significantly improved in both sham and treatment by week 10. </p> <p>Significant reduction MFIS cognitive sub scale score in both sham and treatment by week 10. </p> <p>Significant reduction in MFIS psychological sub scale in both sham and treatment by the end of the treatment period. </p> <p>Both sham and treatment demonstrated a significant reduction in fatigue by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in depression</b> </i><br/> assessed with: BDI ‐II </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both sham and treatment groups showed a significant reduction in values by week 10 (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>). </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Reduction in Spasms</b> </i><br/> assessed with: VAS for spasm </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Both sham and treatment demonstrated a statistically significant decrease in spasm by the end of the treatment (<a href="./references#CD012622-bbs2-0004" title="HughesCM , SmythS , Lowe‐StrongAS . Reflexology for the treatment of pain in people with multiple sclerosis: a double‐blind randomised sham‐controlled clinical trial. Multiple Sclerosis2009;15(11):1329–38. ">Hughes 2009</a>).. </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>VERY LOW</b><sup>1 ,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BDI:</b> Beck Depression Inventory; <b>BI</b> : Barthel Index; FSS: Fatigue Severity ScLE; <b>MFIS:</b> Modified Fatigue Impact Scale; <b>MSIS‐29</b> : Multiple Sclerosis Impact Scale‐29; <b>VAS</b>; Visual Analogue Scale </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup> Downgraded two levels due to high risk of attrition bias and unclear risk of bias in blinding and allocation concealment </p> <p><sup>2</sup> Downgraded two levels due to high risk for imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Reflexology compared to Sham for Chronic Pain in Multiple Sclerosis (MS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012622.pub2/full#CD012622-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012622.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012622-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012622-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012622-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012622-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012622-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012622-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012622\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012622\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012622\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012622\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012622\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012622.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012622.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012622.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012622.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012622.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717403582"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012622.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717403586"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012622.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db714e9199365',t:'MTc0MDcxNzQwMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 